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STRUCTURES OF RISK: LIVED EXPERIENCES OF MULTI-SYNDEMIC 
CLUSTERING IN THE GREATER BOSTON AREA 
NACIELY CABRAL 
ABSTRACT 
 
 People who experience structural violence are an increased risk for health 
conditions including HIV and Hepatitis C. Particularly they are at greater risk for 
experiencing known syndemic interactions between these two chronic infectious diseases. 
The risks are mediated bio-socially through the ways that structural inequality increases 
social and biological vulnerability to illness and suffering. Structural inequalities, or 
experiences of structural violence shape environments of risk; environments of risks 
increase social and biological vulnerability to the structures of risk promoting syndemic 
interactions between biological, behavioral, and psychological conditions. The lived 
experiences of people diagnosed with a combination of HIV, HCV, and mental health 
conditions (MHC) (e.g., mood disorders and depression) are, however, thus far 
understudied. Many aspects and consequences of structural violence and social suffering; 
poverty, homelessness, substance use, lack of access to healthcare, and structural risks for 
HIV, HCV, MHC and interactions between the three. Through this mixed-methods, 
primarily qualitative, ethnographic fieldwork with individuals in the Boston area living 
with HIV, HCV, or both HIV and HCV, or suffering from MHC I ethnographically 
explore people’s perceptions of their vulnerability to these syndemic interactions. I also 
investigate their experiences of being at-risk for these conditions. Through this process, I 
seek to illuminate individuals’ understandings of the impact structures of risk (i.e., 
  vii 
substance use, food insecurity and unstable housing) have on lived experiences with 
HIV/HCV, HIV/MHC, and HCV/MHC syndemics. The perceptions of the lived realities 
of disease-behavioral-psychological interactions and health consequences are analyzed in 
the context of substance use. Substance use’s biological and social dimensions have a 
role in promoting syndemic interactions for each of the syndemics experienced within 
this population. Therefore, substance use is a syndemogenic factor because of its role as a 
mediator for environments of risks, and as a structural risk factor in all three of these 
syndemics. These interactions, and consequential health outcomes, in sufferers’ own 
words, enrich the landscape of syndemics research, producing a clearer picture regarding 
the structures of risks affecting this vulnerable group in the greater Boston area. 
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INTRODUCTION 
 
 
Muffled voices trickle in from the hallway. Django,1 a female health provider at 
the hospital-based clinic that offers free HIV and Hepatitis C medication, the X 
Clinic,2 freezes. I follow suit. She turns her ear to the door, either to put a name to 
the voice or to overhear the conversation. MCM,3 walks in the office, and tells 
Django he just saw her client in the waiting room of the X Clinic and that the 
client smells like vodka. She exclaims, “Good! I’ll go see if I can catch him now.” 
Django turns to me, explaining the client missed his last two case management 
appointments and desperately needed to renew his health insurance paperwork 
and reapply for the Massachusetts HIV Drugs and AIDS Program (HDAP) that 
will pay for his HIV medications. Django opens the door to the hallway and asks 
me if I want to join their consultation – I accept. She walks into the X Clinic 
waiting room. I peer through the glass window on the door to the waiting room, 
but the space appears vacant. Django scans the seemingly empty space; the 
client’s position at the far-left corner of the waiting room hides him from view. 
She walks inside and spots Chester, a middle-aged man with chestnut hair and an 
angular face, swaying in his chair to music emanating from his headphones.  
We greet him, and she lets out a breath. A twitch of her nose lets me know she can 
also smell alcohol wafting from him. When Django asks him about his missed 
case management and primary health care appointments, he replies in Brazilian 
Portuguese, and in hushed tones. Django later explains to me privately this client 
can understand English but prefers to speak in Portuguese. Django urges him, in 
English, to follow her back to her office to complete the HDAP, and a lifeguard 
certification application she thinks will help him get a job, but he declines. Later, 
Django explains that Chester refuses to do the re-application with her at that 
moment because he does not want to lose his spot in the queue waiting for an 
unscheduled doctor's appointment. Especially since, he must pay for the doctor-
visit co-pays out-of-pocket, pending approval for his state insurance that he has 
yet to regain. Chester’s scheduled to meet with his mental health counselor after 
his primary care provider (PCP).  
“Scheduling multiple appointments for the same day helps save up on 
transportation costs,” agrees Django in English and then in Portuguese.  
                                                 
1 To protect the privacy of participants, all the names of individuals and organizations are 
pseudonyms. In the case of “Django,” she only works with clients covered by the Ryan White 
Program at the X Clinic. 
2 The pseudonym, the “X Clinic,” refers to the hospital-based clinic in the greater Boston where I 
conducted my eight-month long internship and fieldwork data collection procedures noted in 
Chapter Two: Methods. 
3 “MCM” is an African-American male health provider at the X Clinic. 
2 
After a few minutes pass, indecision strikes and I awkwardly linger by the 
bookshelf, because even though I cannot hear nor understand most of their 
interaction, Django, and the client both graciously allowed me to join. A stack of 
the February HIVPlus Magazine covers the top of the bookshelf. Then I hear 
Django switch back to English and urge Chester to renew his HDAP documents 
before he leaves: “I will see if we have a transportation pass,” she adds, 
reassuring him that it should also cover the trip to his next appointment. Then, a 
PCP opens the door from the inside of the X Clinic, a welcoming smile on her lips 
as she lets Chester know that she can see him now.  
We return to the private office Django shares with MCM, who then asks, “Did 
you catch him?” Django answers, “He has an appointment, but I’ll see him 
afterward… And yeah, I could smell the alcohol on him, because when you are an 
alcoholic, it does not go away, even if you drink water.” Predicting the forms 
Chester needs to fill out for the state to pay for his HIV treatment regimen and 
living expenses; she opens a cabinet and takes out a physical copy of an HDAP 
application. Then, Django turns to me, “I am trying to help him get a certified 
lifeguard training from the American Red Cross. [Chester] already has the 
experience; he just needs to take the exam.”  
“He needs to get sober first, and the certification costs around $200,” MCM says 
in a matter-of-fact tone.  
“I know… but he needs a job. Hopefully having a job, will motivate him to stop 
[drinking]…” Django’s voice trails off, and I cannot help but think back to the 
quote on the whiteboard attached to the waiting room's wall, next to the knee-
high bookshelf, that caught my eye: “The most common way people give up their 
power is by thinking they don’t have any” by Alice Walker.  
I think of how aptly this quote describes the circumstances that culminate in the 
Chester’s compounded experiences of suffering— Excerpt from field note entry, 
“Shadowing Case Managers” (March 08, 2016). 
As seen in these field notes from early in my time at what I call the X Clinic, 
where I engaged in participant-observation to learn about the structures of risk that 
shaped participants’ lived experiences with HIV, Hepatitis C, interactions between both 
diseases, and other conditions that compounded them, Django hinted that she viewed 
Chester’s reality of financial precarity as an obstacle that hindered his ability to address 
his alcoholism, re-apply for state health coverage, or even complete paperwork ensuring 
access to crucial HIV medications. Especially when Chester used alcohol as a coping 
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mechanism for the financial and health stress he experienced, or in the vicious cycle of 
suffering suggested by his reluctance to miss a medical appointment for which he would 
pay out-of-pocket, to fill out an application that might make the next medical 
appointment free or more affordable. Chester’s alcoholism, as MCM pointed out, further 
impeded his ability to afford even the $200 lifeguard review course, much less the costly 
HIV and HCV treatment therapies.  
While Chester’s mental health condition (MHC) was not specified (but suggested 
by his appointment with a mental health counselor), existing literature showed the 
potential for bi-directional social-psychological interactions between mental illnesses and 
HIV that can worsen HIV progression to AIDS, and contribute to Hepatitis C disease 
acquisition, under conditions of poverty. I chose the term “mental health conditions” 
(MHC) to refer to participants’ experiences regarding the combination of MHC they 
suffer from. Kleinman (2012:118) note mental health is a category that promotes the bio-
medicalization of adverse consequences of social conditions such as, substance use, HIV-
stigma, or family breakdown. Thus, I used MHC as a category encompassing 
psychological and behavioral conditions that intersect with HIV and HCV in syndemics. 
Ethnographic accounts such as the one that began this chapter refined my research on the 
risk environments that produce damaging interactions between disease, behavioral, and 
structural factors, and pushed me to explore other pathways of interaction in the 
qualitative data. While this excerpt did not explicitly classify syndemic interactions, it 
illustrated how participants perceived and experienced risk factors for diseases such as 
HIV in adverse conditions (e.g., substance use, financial precarity).  
 4 
My ethnographic investigation of people lived experiences of HIV, and HCV 
interactions in the greater Boston area began with the following questions: how do 
structures of risk, as perceived by patients and providers, influence syndemic production? 
In other words, how do participants (patients and providers from the X Clinic) describe 
their experiences with syndemic pathways of disease interactions among and between 
HIV and HCV, and the structures of risk that promote them in the greater Boston area? 
As I answered these queries, I also paid attention to how they talked about the role 
overlapping risk factors (social, structural, or biological) played in the production of 
multiple HIV, Hepatitis C (HCV), and mental health conditions (MHC) syndemics.  
My fieldwork focused on people living with HIV (PLHIV), HCV, or both, who 
received medication, mental health and primary care treatment, and disease management 
services including social work, at the X Clinic and exploration of how they dealt with 
day-to-day experiences of disease interaction and the structures of risk that worsened 
their overall suffering. These types of disease interactions are most often produced and 
exacerbated by unequal social conditions, such as poverty, unstable housing, food 
insecurity, structural violence, and stigma, and subsequent conditions of health inequality 
– producing what are called, in medical anthropology, syndemics (Singer et al. 2017). I 
specifically examined how these factors unfolded in the lives of people living with HIV, 
HCV or both, in the greater Boston area. Understanding the contexts that drive syndemic 
interaction and syndemic production is crucial for conceptualizing how disease burden 
magnifies, and social suffering worsened when a population experiences multiple 
syndemics or a cluster of syndemics.  
 5 
I use patients’ and providers’ in vivo perceptions to find the social, psychological, 
and biological environmental risk factors producing multiple HIV and HCV syndemics 
within this group of individuals in the greater Boston area. I use Singer’s use of the term 
syndemic clustering (Singer 2014b), in which he described a set of risk factors for crack 
cocaine-related syndemics. However, I expand on the concept because I argue that the 
same set of risks, or structures of risk, can and do promote multiple syndemics, based on 
a constellation of interactions associated with the production of multiple HIV and HCV 
syndemics in the same population. I posit that similar structures of risk promote syndemic 
pathways of disease/mental health conditions interactions associated with not just 
HIV/HCV syndemics, but also HIV/Mental health condition (HIV/MHC) syndemics and 
Hepatitis C/Mental health condition (HCV/MHC) syndemics.   
Throughout this thesis, I explore narratives from PLHIV, HCV and in so doing; I 
determine and articulate the pathways of disease interactions that affected them. I 
confirmed and found further syndemic interactions between HIV and HCV, and between 
HIV and mental health conditions, and HCV and mental health conditions, produced and 
worsened by substance use, unstable housing, and food insecurity. I characterize the 
structural factors driving the biological/disease/behavioral interactions as structures of 
risks that facilitated and promoted susceptibility to other biological conditions and 
worsened levels of affliction within, and building on, a known HIV/HCV syndemic. 
Participants described how structures of risks, and structural violence, affected their daily 
lives in different ways, allowing me to analyze the same data to confirm and 
contextualize multiple syndemics.  
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Within the context of syndemics, the concepts of social suffering (Singer 2005) 
and structural violence (Galtung 1969) encompasses how unequal health outcomes affect 
the daily lives of the population. Farmer, Connor, and Simmons use structural violence to 
describe the macro-level power dynamics producing and reproducing conditions of 
inequality within a population. Importantly, (Farmer et al. 1996:369) defined structural 
violence as the, “large-scale forces – ranging from gender inequality and racism to 
poverty – which [then] ‘structure’ unequal access to goods and services.” Therefore, 
structural violence creates adverse conditions where individuals are subject to 
stigmatization, and discrimination (Parker and Aggleton 2003), which, in turn promote 
syndemic interactions, and subsequent deleterious health outcomes, especially within 
HIV-related syndemics (Emard 2016; Singer 2011; 2014b). Structural violence is an apt 
theoretical concept that frames the structures of risk perceived by my participants.  
A Syndemic Perspective 
What is appealing about a syndemic approach… is both its explicit emphasis on 
examining connections between health and [social conditions] and its attention to 
routes of transmission that affect clusters of interrelated health problems— Mark 
Nichter (2008:159). 
In the mid-1990s, critical medical anthropologist Merrill Singer coins the term 
syndemics, a combination of two words, syn- (from the concept of synergy) and –emic 
(from the biomedical term, epidemic) (Singer 1994; 1996; 2009; Singer et al. 2013; 
Singer and Clair 2003). Within syndemics, synergy addresses worsened health outcomes 
from the deleterious interaction between “diseases and health conditions of all types (e.g., 
infections, chronic non-communicable diseases, mental health problems, behavioral 
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conditions, toxic exposure, and malnutrition),” (Singer 2009; Singer et al. 2017:941). 
Unlike the term  epidemic, which describes the spread of one disease (Singer 2009; 
2014a), syndemics conceptualizes adverse interactions between multiple entwined 
diseases, and mental health conditions (MHC) (Singer 2014a). Consequently, these 
syndemic interactions promote disease clustering within a population and worsens 
experiences of suffering at the individual level (Gonzalez-Guarda et al. 2011a; 
Mendenhall 2012b; 2016; Mendenhall et al. 2015; Singer 2009; Singer et al. 2017).  
Indeed, syndemics is not synonymous with the biomedical terms, co-infection,4  
superinfection,5 nor comorbidity.6 A syndemic identifies unidirectional and bidirectional 
pathways of disease interactions that shape acquisition and progression of multiple 
deleterious biological conditions. At the micro-level disease interaction of a syndemic, 
co-infection characterizes one of the multiple pathways for infectious and/or chronic 
disease interaction (Singer 2009); superinfection refers to an interaction when the most 
virulent genetic strain is dominant (Singer 2009). Lastly, the syndemics framework 
moves beyond comorbidity because it draws attention to the considerable influence 
social, cultural, and structural contexts have over disease interaction (Mendenhall 2016; 
Singer 2009). Consequently, syndemics provide tools for identifying and drawing 
attention to the biological, psychological, social, and political-economic factors that 
                                                 
4 In syndemics, the term co-infection describes the circumstances when two or more diseases, 
biological conditions, or pathogens and consequentially interact (Singer 2009) 
5 Superinfection describes the interaction between two pathogens composed of genetically diverse 
virulent strands, and a co-infection (Singer 2009). 
6 Comorbidity is a term used in biomedicine to refer to the co-occurrence of more than one 
disease in an individual (Feinstein 1970). 
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engender conditions of disparity, facilitate syndemic interactions (Batchelder et al. 2015a; 
Bulled and Singer 2011; Bulled et al. 2014; Emard 2016; Mendenhall 2016; 2017; 
Mendenhall et al. 2017; Ostrach and Singer 2012b; Romero-Daza et al. 2012; Singer 
2005; 2009; 2010; Singer et al. 2013; Singer et al. 2017; Singer and Clair 2003). 
Why Syndemics? 
Patients do not die of HIV. They die of other causes, mostly overdose— “MCM,” 
a male health provider at the X Clinic (Interview, July 07, 2016). 
In recent years, researchers in public health, and clinical medicine have 
increasingly become more engaged in syndemics research on human immunodeficiency 
virus (HIV), substance use, Hepatitis C (HCV) and mental health conditions (MHC) 
syndemics (DiStefano 2016; Hart and Horton 2017; Loeliger et al. 2016; Morano et al. 
2013; Reece et al. 2014; Stall et al. 2015; Tsai et al. 2017; Willen et al. 2017). Health 
care providers and researchers have long known the impact structural factors have on 
conditions increasing vulnerability to HIV (Brantley et al. 2017; Ostrach and Singer 
2012a; Tallman 2016; Willen et al. 2017), and HCV (Bulled and Singer 2011; Koneru et 
al. 2016; Oramasionwu et al. 2014; Padam et al. 2016; Thomas 2008).  
It is only in the last few decades that HIV, substance use and MHC syndemics 
have been taken into consideration for prevention, treatment and management of an HIV, 
HCV or HIV/HCV co-infection within a population (Chasser et al. 2017; Grebely et al. 
2013; Harris et al. 2015; Hart and Horton 2017; Himmelgreen et al. 2009; Janjua et al. 
2016; Kohli et al. 2014; Padilla et al. 2012; Taylor et al. 2013; The Lancet 2017). 
Syndemics are also useful for developing multidisciplinary intervention where 
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stakeholder (e.g., the sufferers, health providers, primary care physician, mental health 
counselors, nurses, case managers and additional medical staff) work together to identify 
structural barriers to treatment, care and social services (i.e., structural violence) and 
reduce experiences of syndemic interaction among PLHIV, HCV or with both.  
Syndemic Theory  
A crucial component of syndemics as a theoretical construct is the examination of 
how social, cultural, psychological, and structural factors shape not just the burden of 
disease from adverse, mutually exacerbating or sequential biological conditions, but also 
the individual experiences of suffering encountered in a population (Gonzalez-Guarda 
2009; Mendenhall et al. 2017; Singer 2009; Singer et al. 2017; Tsai et al. 2017). Thus, 
biological interactions affecting a disadvantaged community call for employing a 
syndemic perspective for understanding worsening health outcomes within a population. 
Indeed, to meet the criteria, a syndemic must discuss the cooperation between two or 
more epidemics and adverse socio-environmental conditions that intensify the negative 
health effects of these diseases and produce the interactions (Singer 1996; 2009; 2014a). 
Singer introduced syndemic theory in the mid-1990s as a biosocial concept within 
Critical Medical Anthropology (CMA) (Singer 1986). Singer describes CMA as: 
[An] examination of the social origins of dis- ease and ill health in light of the 
world economic system; (2) analysis of health policy, health resource allocation, 
and the role of the State in Third World nations; (3) re-thinking the contemporary 
understanding of medical pluralism; (4) development of a critique of biomedical 
ideology, practice, and structure; (5) attending to the role of struggle in health and 
health care; (6) re-examination of the micro-level of the individual, including 
illness behavior and illness experience, within the context of macro-level 
structures, processes, and relations; and (7) investigation of health and health 
programs in socialist-oriented countries (Singer 1986:1196). 
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A CMA perspective considers health in relation to “access to and control over the basic 
material and nonmaterial resources that sustain and promote life at a high level of 
individual and group satisfaction,” (Baer et al. 2013:5). In other words, a CMA approach 
explores health concerns and the suffering at the macro-level, where large-scale systems 
interact with micro-level factors to promote and perpetuate the political-economic 
conditions in which they occur (Pfeiffer and Nichter 2008; Singer and Clair 2003).  
Rooted within CMA, syndemic theory is essential for the identification and 
implementation of strategies to overcome conditions of social inequities and the 
syndemic pathways of interactions that promote adverse health outcomes. Esther 
Sumartojo (2000) notes how perceptions of risk and acquisition of HIV operate at the 
macro-level: 
At the macro-level, the vulnerability of persons to HIV is influenced by broad 
social structural characteristics. These ‘core’ or distal causes may be far removed 
from individuals’ control, but impact their lives through economic inequalities, 
racism, sexism, discrimination and stigmatization directed towards groups at high 
risk (Sumartojo 2000:S6). 
For example, anthropologist Chaunetta Jones comments on the adverse social conditions 
ethnographic fieldwork exacerbating health outcomes among people living with 
HIV/AIDS (PLWHA) in Grahamstown, South Africa: “Economic inequalities and 
structural barriers have created dire situations that force many PLWHA to choose 
between their economic security and health security,” (Jones 2011:68). Syndemic theory 
critically considers the synergistic, mutually exacerbating link between a cluster of 
biological, social, and cultural factors, rather than only analyzing pathogen-pathogen, 
condition-condition, or disease-disease interactions in a vacuum (Singer 2010).  
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Emily Mendenhall outlines how syndemic theory frames three fundamental rules 
for clustering, a core focus of epidemics and its adverse health outcomes in this thesis:  
[First] the clustering of two (or more) diseases exists within a specific population; 
[second] fundamental contextual and social factors are co-constructed with the 
cluster of these two diseases insofar as they help create the conditions in which 
two diseases cluster and contribute to the further emiseration of the afflicted and 
affected; and [third] the clustering of multiple diseases creates the potential for 
adverse disease interaction, increasing the burden of impacted populations 
(Mendenhall 2016:3).  
Mendenhall’s three guiding principles stem from her argument that syndemics theory 
contributes to biomedical and public health fields by expanding on the concept of 
comorbidity in a more comprehensive definition – including chronicity and illness 
interactions in directly applicable ways. Therefore, syndemics offers immediate avenues 
to pinpoint the biocultural and biosocial contexts and dynamics that drive worsened 
health outcomes and increase suffering within people living with an HIV/opportunistic 
disease co-infection (Ostrach and Singer 2012a; Singer 2014a).  
Relevant Syndemic Interactions 
Singer further argues that the following four conditions are critical to the nature 
and progression of syndemic interactions: 
[One] interactions between humans and their physical environments, including 
other species that harbor, transmit, or promote disease; [two] interactions between 
diseases and human bodies, including our immune systems; [three] interactions 
among diseases within human or animal bodies; [four] interactions between 
human social systems – and their structures of inequality – and diseases, often as 
mediated by the environment (Singer 2014a:198-99). 
These four conditions promote multiple pathways or mechanisms of disease interaction. 
The following four types of syndemic pathways and mechanisms of disease interaction 
are of importance: first is the “alterations or damage done to parts of the body caused by 
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one disease promoting another disease,” (Singer 2014a:203). In other words, biological 
conditions can leave physiological changes that worsen health outcomes.  
Another mechanism of disease interaction addressed in syndemics is: “one disease 
enhances the virulence of another disease” (Singer 2014a:204). For example, Lin et al. 
(2008) conducted a study that showed HIV gp120 enhanced Hepatitis C (HCV) virulence 
by promoting the expression of HCV-regulated transforming growth factor TGF-1. 
Another pathway is when “one disease facilitates the contagiousness of another disease,” 
(Singer 2014a:204). For instance, sexually transmitted infections (e.g., syphilis) cause 
genital lesions which increase the risk of acquiring and transmitting HIV or additional 
STIs (Ostrach and Singer 2012a). Lastly, “diseases [and mental health conditions] may 
interact through behavior,” (Singer 2014a:206). In which case, the social and biological 
dimensions of engaging in the practice of substance use and needle sharing (Figure1B) 
increases the risk of transmitting and acquiring an HIV and Hepatitis C infection 
(Armstrong et al. 2011; Bulled and Singer 2011; Grund et al. 1996; Iversen et al. 2015a; 
Rhodes et al. 2003).  
The map below shows the prevalence of HCV co-infection among groups of 
people living with HIV (PLHIV) who experienced heterosexual contact with HCV 
(Figure 1A), and people who experienced exposure to HCV through injection drug use 
(IDU) (Figure 1B) in North America. 
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Figure 1. Estimated prevalence of HCV co-infection among PLHIV A) who experienced 
heterosexual exposure to HCV and B) people who inject drugs. (Platt et al. 2016:803) 
 
Figure 1 is a map from a meta-analysis, which illustrates that PLHIV and who participate 
in injection drug use suffered from a higher prevalence of HIV/HCV co-infection than 
PLHIV who experienced heterosexual exposure to HCV (Platt et al. 2016:803). Within a 
syndemic, injection drug use is a type of substance use that enables HIV and HCV 
acquisition through participating in risky social behavior such as needle sharing (Figure 
1B). In later chapters, literature and my participants describe risky social and sexual 
behaviors as a structure of risk within HIV and HCV syndemics that promote disease 
interactions.  
HIV/HCV Co-infection: “The Twin Epidemics” 
In an HIV/HCV co-infection, these diseases interact via multiple pathways of 
interactions (Bulled and Singer 2011; Singer 2010); among patients with chronic HCV, 
also acquiring HIV/AIDS is associated with higher rates of mortality (Bica et al. 2001; 
Weber et al. 2006). Consequently, individuals diagnosed with HIV/HCV are at a greater 
risk for hepatic decomposition, and faster rates of fibrosis progression than their HCV 
mono-infected counterparts (Kim 2014). Multiple studies determined that patients with 
both have a more rapid rate of progression to cirrhosis than their HCV mono-infected 
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counterparts (Fierer et al. 2013; Kirk et al. 2013; Osinusi et al. 2009) biologically and 
structurally syndemogenic. Fierer et al. (2013) conducted a study, which reported a 
similar progression to cirrhosis among men who have sex with men (MSM) living with 
HIV and later acquired an HCV infection. Table 1 indicates that as of December 2014, 
there are 3 million people have Hepatitis C (Kohli et al. 2014) and 25% of the 1.2 million 
living with HIV in the United States, are dually infected with HIV and Hepatitis C 
(Centers for Disease Control and Prevention [CDC] 2015). 
Table 1. HIV/HCV dual diagnoses in the United States as of 2014. 
 Diagnosed with 
Hepatitis C (HCV) 
Living with HIV Dual diagnosis of HIV/HCV 
Diagnoses 
(United States)  
3 million 1.2 million Approximately 25% of people 
living with HIV have HCV 
 
Chapter Overview 
In chapter one, “Background,” I present literature by medical anthropologists and 
medical sociologists, recognizing the disproportionate impact of syndemics and syndemic 
pathways of interactions within marginalized and vulnerable populations. To 
contextualize the topic of HIV/Hepatitis C syndemics for marginalized patients and my 
related research questions, I focus on HIV and Hepatitis C syndemic pathways of 
interactions. I outline existing literature on the roles of substance use, MHC, and other 
structural factors within syndemic models including Human Immunodeficiency Virus and 
Acquired Immune Deficiency Syndrome (HIV/AIDS) and substance use (e.g., the SAVA, 
syringe-mediated and crack-cocaine syndemics). In so doing, I clarify what constitutes a 
syndemic. Lastly, I evaluate existing literature on how HIV/AIDS and Hepatitis C 
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syndemics affect people in poverty and other marginalized populations, in the context of 
social inequities that compound these interactions. 
In chapter two, “Methods,” I outline how I conducted a mixed-methods study 
using participant-observation and open-ended semi-structured interviews to gather data 
during my 8-month internship at a Hospital-based clinic offering HIV and HCV treatment 
in the greater Boston area. From ethnographic accounts of the day-to-day experiences 
from or about 35 people diagnosed with HIV, HCV, or both, 14 are interviews with 
people living with one or both conditions, and eight are interviews with health providers. 
For my data analysis, I use modified grounded theory (mGT) data collection and analysis. 
Importantly, I use syndemic analysis of quantitative factors, and I glean them from the 
qualitative data that I gathered. 
For chapter three, “HIV/HCV Syndemic,” I confirm and contextualize a known 
HIV/HCV syndemic as experienced by the affected individuals living with HIV, 
Hepatitis C, or both, in the Boston area. To do so, I present a syndemic analysis of 
quantitative factors gleaned from qualitative and ethnographic data, collected through 
participant-observation and in-depth interviews with people living with HIV, HCV, or 
both, and their providers. I ethnographically illuminate and contextualize the pathways of 
interaction suggested by the apparent interaction between syndemic factors, by 
interspersing my analysis with rich, often difficult accounts from the people directly 
affected and those who care for them. Here I look closely at the effects of HIV/HCV 
syndemics in a small sample of people (six individuals) who experienced an HIV/HCV 
co-infection in contexts of substance use, food insecurity, and unstable housing. 
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In chapter four, “Syndemic Clustering,” I explore how similar structures of risk 
promote syndemic pathways of disease/MHC interactions associated with not just 
HIV/HCV syndemics, but also HIV/MHC and Hepatitis C/MHC syndemics. Here, I also 
illustrate syndemic clustering through two syndemic models. The models reflect the 
experiences of 15 of the 35 participants whose narratives outline the synergistic 
interconnectedness between structural conditions such as food and housing insecurity, 
lack of social support networks, and stigmatization. 
In chapter five, “Substance Use Syndemogenesis,” I use participant descriptions 
of substance use as a key structure of risk that promotes syndemic interactions within all 
three syndemics (HIV/HCV, HIV/MHC and HCV/MHC syndemics). I present substance 
use as a syndemogenic factor. Especially since, it seems to drive the production of multi-
syndemic clustering among people living with HIV, HCV or both in the Boston area.  
I conclude with a confirmation of known HIV and HCV syndemics, 
demonstrating through participant narrative how they experience syndemic interactions. 
Throughout, I discuss the concept of syndemic clustering, highlighting how substance use 
is a key component for syndemic production. Lastly, I recommend further research on 
structures of risks that promote the development of HIV and HCV supersyndemics within 
this population.  
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CHAPTER ONE: BACKGROUND 
 
Informants described a cycle of hunger, HIV, and sex work, in which food 
insecurity frequently prompted sex work. Sex work, in turn, generated heightened 
risk of acquiring HIV, which our informants attempted to manage through eating 
either healthy foods or any food at all, [to] manage their infection and prevent 
side effects from their HIV medication. This increased dependence on food 
created an increased dependence on income generated from sex work— Fielding-
Miller et al. (2014:9). 
 
Within known HIV and HCV syndemics, structural violence is a key part of 
syndemic pathways of interactions. Johann Galtung (1969) coined the term structural 
violence, which operates at a macro-level and refers to the political-economic contexts 
that prevent individuals from accessing affordable health care and social services – 
structural violence is intimately tied to syndemics. Structural violence shapes 
environments of risk that increase susceptibility to interacting diseases, and limit access 
to or affordability of treatment for them (Ostrach and Singer 2012a; Rhodes 2002; 
Rhodes et al. 2005; Sumartojo 2000) in the greater Boston area. I argue that researchers 
using syndemic theory as a framework to explore the impact of HIV and related 
conditions on sufferers must identify the social and political-economic conditions (e.g., 
structural violence, and social suffering) that facilitate HIV, Hepatitis C, and mental 
health conditions (MHC) interactions, and address the exacerbated health outcomes 
within vulnerable populations (Emard 2016; Mendenhall 2014; Ostrach and Singer 
2012a; Romero-Daza et al. 2012; Singer 1996; 2011; Singer et al. 2017; Singer and Clair 
2003).  
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To understand the complex interconnections of HIV, HCV, and mental health 
conditions, and the consequences of syndemic interactions between them, it is also 
important to first differentiate between disease and illness. Disease refers to the deviation 
from biological pathways established by Western medicine (Chrisman 1977; Fabrega 
1972). Particularly, “an occurrence of disease embodies a cluster of negative deviations 
in an individual's various interconnected systems (i.e., chemical, physiologic)” (Fabrega 
1977:208). Illness refers to the “psychological [component] of disease” (Kleinman 
1977:118), which involves the sick person's social, cultural understanding of illness, the 
coping mechanism for these conditions, and the forms of treatment available to the sick 
person to seek help from. In addition, Fabrega (1977) concludes that illness and disease 
depend on the social and physical environments of the individual strikes close 
to syndemics. Therefore, I begin this chapter with a discussion of the literature supporting 
HIV as a syndemogenic factor – likely to result in disease interactions in structural 
context. Then, I present several known biological, social, psychological, and structural 
factors and discuss their role within HIV and HCV syndemic interactions. Lastly, I 
discuss three known syndemics – the SAVA (substance use, violence, and AIDS), 
syringe-mediated and crack-cocaine syndemics. 
Special Vulnerabilities, Special Resources  
For those who struggle each day to feed their families, maintain a safe and secure 
roof above their children’s heads, and participate in the local and inevitably global 
economy, everyday life can be stressful. Understanding the complexities of the 
causes and consequences of such stress on the health and social well-being of 
marginalized and impoverished groups is a central goal of medical 
anthropology— Mendenhall (2016:166). 
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Known HIV and HCV syndemics research focuses on vulnerable populations 
(e.g., MSM, women in poverty, people who engage in substance use) who face conditions 
of structural violence and social suffering, and experience worsened health outcomes 
(Mustanski et al. 2011; Platt et al. 2016). People living with HIV, HCV, or both 
conditions, face structural factors (e.g., economic instability, food insecurity, and lack of 
access to health care and social services) that worsen disease clustering within a 
population, which in turn, compounds experiences of suffering at the individual level 
(Romero-Daza et al. 2003; 2005; Singer 2005; Singer et al. 2017). Before addressing the 
structural factors within known SAVA (substance use, violence, and AIDS), syringe-
mediated and crack-cocaine syndemics, it is important to discuss how structural violence 
perpetuates the synergistic cycle of disease and illness clusters within a vulnerable 
population (Mendenhall 2012a).  
Structural Violence 
Farmer et al. (1996:369) expanded the concept and defined structural violence as, 
“the large-scale forces – ranging from gender inequality and racism to poverty – which 
[then] ‘structure’ unequal access to goods and services.” In other words, structural 
violence is a term that describes power relationships and how social structures shape 
one’s ability to access services (Ostrach and Singer 2012a). Therefore, structural violence 
as a social condition creates adverse situations where individuals are subject to, for 
example, poverty (Parker and Aggleton 2003) which, in turn, promotes syndemic 
interactions, and subsequent deleterious health outcomes, especially within HIV-related 
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syndemics (Emard 2016; Gonzalez-Guarda et al. 2011a; Gonzalez-Guarda et al. 2011b; 
Ostrach and Singer 2012b; Singer 2014a).   
Paul Farmer’s description of structural violence further describes the relationship 
between structural risk factors (e.g., poverty), health, and social suffering with the term 
structural violence. He writes, “Social arrangements… systematically bring subordinated 
and disadvantaged groups into harm’s way and put them at risk for various forms of 
suffering” (Farmer 2004:307-08). Structural violence encompasses the violence of 
poverty, social and political marginalization, racism, sexism, and other forms of 
structured inequalities and their effects on people’s lives, health, and agency (Farmer 
2003a; 2004). Structural violence shapes vulnerability and resilience and mediates 1) the 
experience of conflict, 2) individual and social responses to conflict, 3) and hence the 
health outcomes of conflict. Thus, structural violence robs people of access to resources, 
creates food insecurities, and strengthens the reciprocal synergism of poverty and poor 
health (Bourgois and Schonberg 2009). Under these conditions, syndemics builds upon 
political-economy of health perspective to find and explore the structures of risk that 
promote excessive health risks and suffering among and within vulnerable, often poor 
populations. 
Gilligan (1997) noted a relationship between mortality rates and those who have 
experienced structural violence: 
The increased rates of death and disability suffered by those who occupy the 
bottom rungs of society, as contrasted with the relatively lower death rates 
experienced by those who are above them (Gilligan 1997:192). 
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In so doing, Gillian made an association between class, income level and mortality rates 
that suggested poverty as a form of structural violence. Inability to afford HIV or HCV 
health care treatment and medication further compromises the immune system and 
promotes disease interactions (Aidala et al. 2016; Batchelder et al. 2015b; Chasser et al. 
2017; Mandorfer et al. 2016; Michel et al. 2016; Padam et al. 2016; Reed et al. 2016). 
Therefore, access to technological and medication advances, as they influence the lived 
experiences of people living with HIV (PLHIV) and other biological conditions such as 
Hepatitis C, are also relevant to this discussion.  
Mendenhall (2012a; 2014) expanded on the role of structural violence in lived 
experiences with syndemics, applying the medical-anthropological concept of social 
suffering (Kleinman et al. 1997) to syndemics research by developing the combined 
theoretical framework of syndemic suffering to refer to lived experiences of  interactions 
between violence, poverty, diabetes, depression, immigration, and substance use among 
Latina women in Chicago.  
In other words, syndemic suffering links structural violence to interwoven 
socially and structurally driven adverse biological conditions, such as diabetes and 
depression (Mendenhall 2012a; 2014; Mendenhall et al. 2015), producing increased 
suffering illuminated by ethnographic research on syndemics. Therefore, syndemics 
research reflects the unique, and neglected, health needs of people at-risk for acquiring 
multiple infectious diseases and experiencing suffering. 
 
 22 
National and State HIV & HCV Medication Programs 
A specific form of structural violence can be seen in the denial or delaying of 
access to health care (Ostrach and Cheyney 2014), which can particularly affect people at 
risk for HIV/HCV syndemics. In 1990, Congress passed the Ryan White Comprehensive 
Resources Emergency Act to increase health care services for people living with HIV 
(PLHIV) (Johnson and Morgan 2007). Established in 1990, revamped in 1996, and 
reauthorized and amended in 2000, the Ryan White Program financially assists PLHIV 
with needed medications at the state level, protecting their right to access HIV treatment 
and medication (Johnson and Morgan 2007). The U.S. Department of Health Resources 
and Services Administration (HRSA) and HIV/AIDS Bureau (HAB) administer the Ryan 
White Programs (Cope et al. 2016). The national HIV/AIDS Drug Assistance Program, 
which functions under the Ryan White Program in each state which participates, 
including Massachusetts, is a financial “safety net” for low-income PLHIV (Bassett et al. 
2008). These programs are crucial for improving access to HIV medications among 
vulnerable populations experiencing financial precarity.  
In Massachusetts, people living with HIV who earn a gross annual income that 
below 500% of the US federal poverty level (FPL), or about $60,300.00 or less as of 
2017, are eligible to enroll in programs such as the Massachusetts HIV Drug Assistance 
Program, HDAP, which is the local provider for Ryan White Program services (HDAP 
2016). However, Massachusetts recipients must also have health insurance – for many 
Ryan White Program beneficiaries in Massachusetts, this is MassHealth, a state Medicaid 
program that provides health care services for low-income residents living at or below 
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185% of FPL (Freyer 2016; Gross et al. 2016). HDAP is thus a “payer of last resort” for 
HIV-related medication co-pays, for those who cannot afford them (HDAP 2016). Even 
if an HIV-positive person in Massachusetts succeeds in getting HDAP coverage, they 
may need assistance from covered physicians, nurse practitioners, social workers, and/or 
case managers to understand their treatment regimen, manage any co-occurring (or 
syndemic) conditions, and to navigate state health insurance systems to receive related 
care. While HDAP, as the Ryan White Program provider in Massachusetts provides HIV 
medications to eligible participants, it does not provide Hep C treatment, to people living 
with both HIV and HCV, or to people who acquire an HCV infection after already living 
with HIV, as is common. People with HIV who also need HCV treatment must rely on 
MassHealth or other health insurance for their any needed HCV treatment. 
Given that HIV/HCV co-infected individuals have a higher chance of dying of 
liver disease (Kirk et al. 2009; Lin et al. 2013; Sohn 2016) or liver cancer (Ryerson et al. 
2016; Sarkar et al. 2015; Sogni et al. 2016; Stanaway et al. 2016), the Ryan White funded 
clinics are, however, expected to provide and to improve access to HCV treatment for 
HIV/HCV co-infected individuals (Cope et al. 2016). Treating HCV before treating HIV, 
among people living with both, slows down the progression of liver fibrosis before it 
becomes fatal (Arends et al. 2015; Fierer et al. 2013; Hernandez and Sherman 2011; 
Miyamura et al. 2016; Thomas 2008). HCV therapy followed by highly active 
antiretroviral therapy (HAART) has yielded a reduction in fibrosis progression and 
cirrhosis-related mortality (López-Diéguez et al. 2011; Macías et al. 2006). 
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An evaluation of Medicaid policies for reimbursement of sofosbuvir, a drug used 
in treatment for HCV, showed that individuals with advanced fibrosis had limited access 
to HCV therapies (Barua et al. 2015). One contraindication was a person’s substance use 
status (Davis and Rodrigue 2001; Harris et al. 2015) and the other was a person’s existing 
mental health condition (MHC) (e.g., depression and anxiety disorders) (Goossens et al. 
2016; Johnson et al. 2002; Johnson 2003; Mark et al. 1998). These conditions thereby 
limit the eligibility criteria of therapies for HCV (Barua et al. 2015). This was because 
“old” HIV/HCV therapy (i.e., using PEGylated interferon (PEGIFN) and ribavirin (RBV) 
with joint antiretroviral therapy (cART) increased the chances of developing exacerbated 
psychological conditions (Blacklaws et al. 2011). Unfortunately, Mehta et al. (2005) note 
that the measurement for liver disease is not uniform and can be too costly; medications 
for HCV therapy cost more than $1,000 (Harper 2015). Thus, some individuals 
experience limited access to HCV treatment therapy (Mandorfer et al. 2016), even when 
they are at demonstrably higher risk for HIV and HCV interactions for the very reasons 
that limit their treatment options.  
Although states continue to place disease-related and financial restrictions on 
HCV therapies it was not until August 2016 when negotiations between MassHealth and 
Gilead Sciences, Inc., a pharmaceutical company, resulted in a rebate, which lowered the 
price of Harvoni, a first-line medication for HCV treatment (Executive Office of Health 
and Human Services [EOHHS] 2016; Freyer 2016). On October 2014, the U.S. Food and 
Drug Administration (FDA) approved Gilead Sciences’ Harvoni to treat HCV genotype 1 
infections (Raedler 2015). Harvoni is an interferon-free (IFN-free) combination of the 
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drugs ledipasvir and sofosbuvir (Gritsenko and Hughes 2015). Unlike ribavirin, Harvoni 
is a once-a-day oral combination that does not need to be co-administered, making it 
more efficient than the “old” HIV/HCV therapy regimen (Gritsenko and Hughes 2015; 
Raedler 2015). Therefore, using “new” interferon-free (IFN-free) and direct-acting 
antivirals (DAA) to treat and cure HCV, among people also living with HIV, is a 
preferred treatment regimen for HIV/HCV co-infected individuals (Cope et al. 2016).  
Human Immunodeficiency Virus – The Perfect Syndemogenic Factor 
HIV/AIDS is caused by a lentivirus that destroys the host immune system and is 
characterized by its rapid mutation and reproduction (Condon and Sinha 2008:6-7). The 
virus replicates via the division mechanisms of particular cells in the immune system, as 
well as some glial cells and nervous system neurons; they have to be cells with cell-
surface receptors capable of interacting with the viral envelope protein (Lodish et al. 
2007:159). If not treated with antiretroviral, and carefully managed, the virus quantity 
increases in the blood, simultaneously destroying CD4+ cells—T-lymphocytes from the 
host immune system (Condon and Sinha 2008). This process enhances the risk of the host 
acquiring a co-infection (e.g., of tuberculosis, sexually transmitted diseases (STDs), and 
malaria) (Singer 2010).  
A huge body of literature demonstrates the syndemogenic nature of HIV, in 
interaction with other diseases and conditions including sexually transmitted infections 
(Adimora et al. 2006; Cheney et al. 2014; Fenton et al. 2014; Gruskin et al. 2007; 
McLellan-Lemal et al. 2012; Singer et al. 2006), mental health conditions (Altice et al. 
2010; Brown et al. 2000; Bulled and Singer 2011; DiStefano 2016; Eisenberg and Blank 
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2014; Gonzalez-Guarda et al. 2011a; Illangasekare et al. 2014; Iversen et al. 2015b; 
Johnson 2003; Mustanski et al. 2007; Senn et al. 2010; Wyatt et al. 2002), and 
malnutrition (Bulled et al. 2014; Everett and Wieland 2012; Himmelgreen et al. 2012; 
Ostrach and Singer 2012b; Romero-Daza et al. 2012; Singer and Clair 2003). More than 
40 years ago, Scrimshaw et al. (1990) discovered the “nutritionally acquired 
immunodeficiency syndrome” which refers to the process in which malnutrition 
negatively affects the immune system’s ability to fight off disease at the cellular level. 
Later, Chandra (1997) noted the cyclical and synergetic interaction between malnutrition 
and infectious agents and named the synergetic relationship “nutrition-infection 
complex.” Indeed, HIV disease is remarkably syndemogenic (syndemic-causing) 
particularly because of how the HIV pathogen destroys the immune system, increasing 
the risk of acquiring a co-infection and promoting deleterious health outcomes within 
unjust social environments (Singer 2010; 2014a:208). 
Biological Factors: Accelerated Liver Fibrosis Progression 
HIV and HCV promote hepatic fibrosis of the liver. Since HIV compromises 
CD4+ T cell function, these immune cells become depleted, and result in a higher viral 
load. This reduces CD4+ cells’ ability to stimulate Natural Killer (NK) cells (Glässner et 
al. 2013). Inactive NK cells thus cannot inhibit fibrosis among HIV/HCV co-infected 
individuals, resulting in accelerated fibrosis progression (Miyamura et al. 2016). 
Additionally, with a depleted CD4 + T cell quantity, the autoimmune response becomes 
compromised, which also depletes the lymphoid tissue of the intestines. In doing so, the 
host is more susceptible to bacterial infections (Lin et al. 2013). A compromised 
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autoimmune system cannot protect against exposure to lipopolysaccharide (LPS), a part 
of the Graham negative bacteria that can begin hepatic fibrogenesis.  
People diagnosed with HCV have higher levels of LPS (Sandler et al. 2011), 
suggesting that HIV/HCV co-infected individuals have a compromised autoimmune 
system that does not protect against cirrhosis (Balagopal et al. 2008). The resulting higher 
levels of LPS bind to Toll-like receptor 4 (TLR4) on human hepatic stellate cells (HSC), 
thereby activating HSC and promoting hepatic fibrosis (Miyamura et al. 2016). In other 
words, an HIV/HCV co-infection worsens the level of affliction (e.g., accelerating 
scarring of the liver) as well as increasing susceptibility and vulnerability to other 
infectious agents or psychological conditions.  
Furthermore, excessive alcohol use decreased HIV and HCV treatment efficiency, 
which then accelerated development of AIDS via changes in CYP2E1 and CYP3A4 
activity (Kumar et al. 2012). This association must be noted because approximately one 
fourth of people newly diagnosed with HIV engage in the practice of excessive alcohol 
consumption (Barve et al. 2010). Additionally, Wit et al. (2002) report higher 
hepatotoxicity in HIV/HCV co-infected individuals undergoing highly active 
antiretroviral therapy (HAART) who also abuse alcohol. The report suggested that 
excessive alcohol use among vulnerable HIV/HCV co-infected individuals undergoing 
HAART resulted in possible harmful liver and autoimmune condition. 
Importantly, structural and social inequalities shaped the harmful social and 
political-economic and behavioral conditions which then increased a population’s 
vulnerability for HIV, HCV, and MHC syndemic interactions (Bruce et al. 2011; Emard 
 28 
2016; Kelso et al. 2014; Mendenhall 2012a; Mendenhall et al. 2017; Meyer et al. 2011; 
Operario and Nemoto 2010; Romero-Daza et al. 2012). As such, the structural factors 
described below were crucial for the development of syndemic pathways of interactions 
between HIV, HCV, and MHC.  
Structural Factors: Syndemic Interactions 
Bulled and Singer (2011) identified the social and structural factors that facilitated 
syndemic pathways of disease interaction between HIV and HCV, and the subsequent 
worsened experiences of suffering. They found that age drove syndemic interactions 
because younger individuals were more likely to financially depend on someone who is 
more experienced with substance use practices. Engaging in the practice of drug use at an 
early age increased the risk of drug sharing and syringe sharing practices over a longer 
length of time (Grund et al. 1996; Olsen et al. 2013; Palmateer et al. 2010; Rourke et al. 
2011; Strike et al. 2004). Given the deleterious health consequences of substance use and 
HIV/HCV co-infection discussed earlier in this chapter, the length of time an individual 
engaged in illicit substance use practices further promotes hepatocellular fibrosis 
progression (Miyamura et al. 2016) and development of AIDS (Kumar et al. 2012). 
Traditionally, literature focused on how gender inequalities promoted worsened 
health outcomes among people living with HIV and HCV. Literature explored how men 
who inject drugs (MWID) forced or coerced their female partners into injection drug use, 
increasing women’s vulnerability for an HIV, HCV, or HIV/HCV co-infection (Iversen et 
al. 2015a; Iversen et al. 2015b; Olsen et al. 2013; Scott et al. 2013). Recently, Ellen 
Tuchman (2015) conducted a qualitative study revealing that some women who were 
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inexperienced in the practice of substance use sought out or relied upon experienced 
women for access to drugs and syringe paraphernalia. Tuchman (2015) found that the 
women who were more experienced with illegal or excessive substance use controlled the 
access to clean syringe paraphernalia, which increased the risk of acquiring HIV among 
inexperienced women. As Tuchman hinted, gender, social networks and the amount of 
experience influenced access to drug and syringe paraphernalia, which further 
exacerbated health risks among women at risk for an HIV, HCV or HIV/HCV co-
infection.  
People living with HIV, HCV or both who experienced conditions characterized 
by structural violence and social suffering may have also experienced racism (Linton et 
al. 2016). Racism increased the risk of internalizing the social negative stereotypes 
regarding their ethnicity on top of the interactions racism has with substance use as social 
factor (Friedman et al. 2016; Kelso et al. 2014; Mokotoff 2011; Rhodes et al. 2005; 
Sanders-Phillips 2002; Wilson et al. 2014; Woerner et al. 2016). Additionally, the 
location of residence stands for the environment of risk driving syndemic interactions 
(Bulled and Singer 2011). A lack of access to health care, and unstable housing increases 
vulnerability for acquiring an HIV and/or HCV infections (Riley et al. 2015). Riley et al. 
(2015) found that impoverished women who experience unstable housing are at risk for 
engaging in substance use. Bungay et al. (2010) conducted an ethnographic study and 
found that women living with HIV who experienced unstable housing took part in crack-
cocaine use as a coping mechanism for the emotional and physical pain.  
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Unstable housing indicates inability to afford housing expenses, which then 
suggests financial instability and potential food insecurity. In 2001, the United Nations 
Subcommittee defined food insecurity as “the limited or uncertain availability of 
nutritionally adequate, safe foods, or the inability to acquire personally acceptable food in 
socially acceptable ways.” Limited access to food services further compound health 
outcomes among PLHIV because food insecurity coupled with HIV increases the risk of 
medical hospitalizations and emergency room visits (Weiser et al. 2013). Lastly, PLHIV 
who experience unstable housing also engage in substance use practices, which not only 
affect the risk for an HIV/HCV co-infection, but also the development of mental health 
conditions (Kalichman et al. 2014; Kalichman et al. 2015). PLHIV, HIV or both face 
conditions characterized by poverty; poverty then drives multiple syndemic interactions, 
producing disease clusters and suffering (Mendenhall et al. 2017; Ostrach and Singer 
2012a; Singer 2014b; Tsai et al. 2017).  
Known HIV and HCV Syndemics 
Ever since the 1980s, awareness of HIV/AIDS and its compounding effects on co-
infections is growing – yet co-infection and syndemic interactions are not the same 
(Singer 2010). The HIV and viral Hepatitis C (HCV) co-infection are notoriously known 
as the “Twin Epidemics” because the viruses share similar transmission qualities 
(Highleyman 2003). Syndemic researchers go beyond co-infection or shared routes of 
transmission to show how HIV and HCV, and structural risk factors for both illnesses, 
intertwine and interact to increase the burden of suffering for people affected by both. 
Therefore, to best understand the syndemic conceptualization for exacerbated health 
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outcomes in marginalized populations, it is imperative to also explain the pathways of 
disease interaction. 
The SAVA Syndemic 
Singer (1996) recognized the first syndemic – the SAVA (substance use, violence, 
and AIDS) syndemic among low-income inner-city Puerto Ricans residing in Hartford, 
Connecticut in the United States. During a longitudinal study using community-based 
methods, Singer noticed the harmful effects of poverty, inequitable health care, high 
employment precarity, housing insecurity, interpersonal violence, and substance use on 
the AIDS epidemic. Initially identified after exploring the multidirectional relationships 
between substance use, interpersonal violence, and AIDS in the context of inner-city 
poverty and discrimination, Singer’s syndemics theory outlined the role of social 
problems as they work in conjunction to exacerbate all three threats to health 
simultaneously. The SAVA syndemic linked infectious diseases (HIV/AIDS) with 
behavior-associated diseases (substance use), and interpersonal factors (violence 
victimization, especially intimate partner violence), in the context of social conditions 
(poverty and discrimination) that compounded the disease interactions (Singer 2009). 
Following recognition of the SAVA syndemic example, the Centers for Disease Control 
and Prevention (CDC) acknowledged the value of a syndemics orientation for its 
potential to influence how infectious diseases (e.g., HIV, tuberculosis, viral Hepatitis C, 
and sexually transmitted infections (STDs) were perceived and treated as multifaceted 
health phenomena (Fenton et al. 2014).  
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Syringe-mediated Syndemics 
Syringe-mediated syndemics describe the multiple biological and structural 
pathways of interaction in HIV/injection drug use (IDU) syndemics. Specially those 
interactions that stem from HIV’s ability to compromise an individual’s immune system, 
which then increases the risk of acquiring a disease and produces disease interaction 
between HIV and Hepatitis C. In an HIV/HCV co-infection, the diseases interact via 
multiple pathways of interaction (Bulled and Singer 2011; Singer 2010). Bulled and 
Singer (2011) analyzed the known literature and statistics, considering the biological 
pathogen-pathogen interaction that can occur in a syringe. Due to the nature of syringes 
being conductors of diseases, the sharing of needles among people who inject drugs 
(PWIDs) increase the risk of multiple pathogen-interaction, which then, worsen 
morbidity and mortality rate among this population (Bulled and Singer 2011; Singer 
2010). For example, Dumchev et al. (2009) conducted a study of an acetylated opioid 
mixture made from poppies in Ukraine (i.e., hanka) revealed its use among people who 
inject drugs have a prevalence of HIV infection of 14% and a prevalence of HCV 
infection as 73%. The population in Ukraine who injected drugs had a 12.1% change of 
acquiring an HIV/HCV co-infection (Dumchev et al. 2009). As such, this study suggests 
that there is something either biological, social, political or economic that makes this 
population disproportionately affected.  
Furthermore, Macías et al. (2006) conducted a study of 135 individuals living 
with HIV and HCV who had undergone liver biopsies for three years, concluding that 
28% progressed into the next stage of fibrosis, 16% pressed by two stages of fibrosis, and 
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at least 13% developed cirrhosis. Netski et al. (2008) performed a study which associated 
higher levels of HCV vireo among people living with HIV than those who are HIV-
negative. Two other studies noted the relationship between higher levels of HCV viral 
loads and increased risk for HIV progression to AIDS (Daar et al. 2001; Kovacs et al. 
2010). These studies show that individuals dually infected with HIV and HCV experience 
worsened health outcomes than those who are living with a mono infection of either 
disease.  
Crack-Cocaine Syndemics 
 Singer (2014b) found a crack-cocaine syndemic, where crack and cocaine use 
lead to worsened health outcomes among its sufferers. In this article on infectious disease 
syndemics of crack-cocaine, Singer first used the term STI clustering (which I also 
employ in relation to structural risks that produce multiple interactions related to HIV and 
HCV), to describe the syndemic relationships between crack, cocaine, STIs (e.g., genital 
herpes, chlamydia, and syphilis), interpersonal violence, and poverty (Singer 2014b). 
Singer also outlined that, like syringe-mediated syndemics (Bulled and Singer 2011), 
crack cocaine syndemics result from and facilitate the spread of sexually transmitted 
infections (STI). Thus, increasing the likelihood of disease interaction between HIV and 
other STIs, as well as with other infectious and chronic illnesses.  
For instance, Singer (2014b) notes that crack and cocaine syndemics explore 
worsened symptoms and hindered access to treatment among individuals who may also 
be infected with tuberculosis (TB). Particularly, crack-cocaine syndemics address how 
conditions of substance use promote the risk for an HIV or HCV co-infection. Cocaine 
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increases the production of catecholamines, biogenic amine neurotransmitters that 
include dopamine, epinephrine (adrenaline) and norepinephrine (noradrenaline), 
consequentially depleting the amount of these molecules (Brooks 2015; Lodish et al. 
2016). As such, prolonged cocaine use may result in depression (Brooks 2015), which 
alludes to pharmacological effects substance use has on the mental health condition and 
HIV risk of the sufferer (Eisenberg and Blank 2014; Gonzalez-Guarda et al. 2011a; Loftis 
et al. 2006; Walkup et al. 2008). Lastly, syndemics research highlights the progression of 
HIV viral load, thereby increasing vulnerability to opportunistic diseases, especially since 
substance use, and food and housing insecurity all affect the sufferer’s mental health and 
ability to adhere to HIV medication (Kalichman et al. 2014; Singer 2014b; Surratt et al. 
2015; Turan et al. 2017; Whittle et al. 2016).  
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CHAPTER TWO: METHODS 
 
 
Figure 2. Entrance to the X Clinic. 
I fix my collar as I adjust my volunteer badge, which dangles, from my neck 
before opening the door to the X Clinic. The waiting room lays empty except for 
the magazines neatly stacked on top of the knee-height table nearest to the 
entrance through which I pass. I make eye contact with a dark-haired woman – 
her straight black bangs fall neatly on her forehead, concealing her eyebrows. I 
tap my badge to the door and wait for it to turn green. I start to panic a little, as it 
does not open; the little red light taunts me. I peek my head toward the front desk, 
smile and wave to catch the attention of the Front Desk staff, signaling to my 
badge and asking if they could please open the door. She disappears from my line 
of sight, and the light turns green, allowing me entrance into the X Clinic. I pass 
by the glass window and nod and smile with what I hope is gratitude towards the 
Front Desk staff that buzzed me in. I walk to the back of the X Clinic, and right 
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before the getting to the EXIT door at the very end of the corridor; I make a left 
and see that Sam, the mental health counselor’s room is open. I knock and peek 
my head in. Sam is sitting facing her desk and she twists to see who it is although 
she does not stop typing. When she sees that it is I, she smiles, swivels her chair to 
stand and face me. I greet her and shake her hand. She tells me she is excited to 
have me here as she glances at the clock and motions for me to follow her out the 
door. 
She tells me that her 9 AM patient just arrived and asks if I would like to observe 
her appointment, if the patient allows me to sit in, that is. I eagerly nod my head, 
clutching my bag behind me to hide my enthusiasm. A nurse stands by the door 
that would not let me into the X Clinic before, and smiles in greeting, saying hello 
to someone not in my line of sight. She waits there, by the door to the X Clinic, 
and I, not wanting to crowd them, stand by the door to the Front Desk, wishing 
that I could have a place to drop my coat and bag before meeting the patient. Sam 
introduces me and I greet the female patient, “Rose,” bowing my head slightly, a 
nervous smile twitching the corners of my lips when I meet the patient's eyes and 
say hello. I notice Rose wears a bright red hoodie, with white letters on the front, 
worn-out jeans, and black sneakers. Her thin brown hair is pulled back in a 
ponytail. She merely glances at me, acknowledging my presence for the slightest 
of seconds, lips quickly twisting in dislike (I think) before she dismisses me. Rose 
follows Sam to her office, and I trail behind, unsure if I could sit in during the 
appointment. Once at the office, Niki informs Rose and me that I am only here for 
five minutes and that I will not stay for the entire duration of the appointment. At 
that, Rose seems to relax slightly into her chair – her shoulders slump as she 
adjusts her elbows to rest on top of her knees. She sits in the middle of the chair, 
as if uncertain if she wants to stand up or lean back on the chair completely. 
Disappointment threatens to unravel my smile, at her discomfort, and I do my best 
not to show it. Rose sits directly across from Sam, who faces Rose, her back to the 
darkened computer screen as they begin to exchange pleasantries, inquiring 
about each other's family. 
Rose sits at my right, while Sam sits at my left and I do my best to pay attention to 
their exchange. Rose talked about how her daughter had her sixth child, and I 
congratulated her on the new family member. At that moment, she turns to face 
me, under the office's lighting, I get a closer look at the bags under her eyes, and 
her mouth set in a straight line. It was then that I realized that having a new 
family member may not exactly be a cause for celebration as she gives me a slight 
nod, one side of her mouth twisting again, in something like a “nothing I can do 
now” gesture, her eyes moving upward to a spot above my head. After a few 
seconds of silence, I ask if she has many granddaughters and she says she has a 
few and talks about how she is now in the search for a new place to live because 
even though she carries two jobs, her home is too crowded to relax there. The 
room falls into silence once more, and I begin to grow nervous, thinking I had 
over-stayed my welcome by accidentally maybe bringing up a sore topic. My eyes 
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search Sam’s face, focused on Rose, as if waiting patiently until the Rose was 
ready to speak. After a few more seconds, I grow more self-conscious, and I get a 
distinctive feeling that Rose is not willing to discuss more of her private life with 
me in the room. Uneasiness grips my stomach and I am not sure if I did something 
for the patient to not like me. 
I look at the clock and notice my five minutes are up and even If I wanted to stay, 
I did not want to take time from an appointment by making it more difficult for 
Rose to talk about what was important to her. I exclaim that I am so sorry and 
that it was a pleasure meeting Rose. I gather my bag and coat and walk the two 
steps out of the office, the soft click of the lock sounds behind me as I close the 
door and make my way to an empty office room next to the Triage Station in the 
hallway. I found myself unsure of where to put my stuff and about how to 
proceed— Excerpt from field note entry, “Searching for a Site” (March 01, 2016). 
 
Here I detail the events that resulted in a seven-month search for an internship, and then 
fieldwork position, at a community-based organization offering services to people living 
with HIV, HCV or both. The first site where I offered to volunteer, a community health 
center with a specific HIV and HCV program, I was only able to attend twice with each 
visit lasting up to 2 hours; I spent these hours hashing out the details of volunteering 
requirements and the paperwork needed to complete to join the organization. However, 
there were scheduling conflicts and unexpected requirements that made it difficult to 
confirm a position. After my acceptance as a volunteer with, my would-be supervisor 
informed me that the organization could no longer support a volunteer position because it 
was undergoing staffing and organizational changes, including ending the HIV/HCV 
program for lack of a program coordinator, and that this meant they would be letting go 
all related volunteers.  
Suddenly without a site I had waited patiently to confirm, and limited 
opportunities to volunteer in the Boston area with my desired population of individuals 
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living with both HIV and HCV, I thought back to when I first visited the site from which 
I had just been released: 
We walk into an office space. A dark-skinned woman with a complicated dread 
pattern with streaks of purple and a silk purple blouse sits at her desk found next 
to the door we walk through; she looks up when a Staff member opens the door all 
the way to let me in. I do a quick wave hello as the Staff member introduces me – 
“this is Naciely, a current BU Masters student interested in volunteering for us. 
She is interested in HIV, women, and stigma.” I open my mouth to explain, 
respectively, that stigma is not what I was focusing on and that he forgot to say 
Hepatitis C as well, but as I try to speak, I stammer and end up just saying hello 
once more. The woman in the silk asked me if I was nervous and I nodded, as I 
replied, “Yes, sorry.”  
“Don't be! Relax, 7 this is not an interview!” she exclaims as she turns her focus 
to her computer screen after a quick beep, which I assumed indicated that she had 
a new email message. This comment completely baffles me because all this time I 
thought that this was an interview… Therefore, I just laugh awkwardly. Slowly, I 
nod as I feel my cheeks go from hot to scalding from embarrassment— Excerpt 
from field note entry, “Site: First Attempt”  (Field note, October 29, 2016). 
That encounter had made me feel like I was next in line at the grocery store and I had just 
realized someone had replaced all my cash with monopoly money. I wanted to make the 
best impression possible, but as I debated over how I should correct the person who was 
introducing me, not only had I missed my chance to explain I was interested in Hepatitis 
C, I had also lost track of the change in a conversation I was to take part in.  
What was worse than the embarrassment I felt that day was the disheartening 
email I received in December 2015, mere hours before my birthday, telling me that my 
approved volunteer position had become unavailable as soon as it had begun, because the 
program supervisor for the program I would be working with had left abruptly. 
                                                 
7 Underlined sections within quotes or field notes represent the words and phrases participants 
emphasized with inflections in their voice.  
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Unfortunately, I learned this while reading an email on my phone, while I was waiting at 
the site, expecting to start my first day in the internship: 
I sit in the open space where multiple people in pale blue or black jeans and 
hoodies lounge around, talking amongst themselves; some watch the TV screen 
above them in the corner. Pictures of smiling faces litter the wall. I feel out of 
place and over-dressed in my dark slacks, suede boots, red silk blouse and 
cardigan sweater; I avoid eye contact with the other individuals because I am not 
sure about what I would even say to them or if I could talk to them. I am anxious 
because I feel like I everyone is staring at me. To keep me occupied while I wait 
[to start my volunteer hours], I get up to take a closer look at the pictures. I read 
one of the notes next to the closest photograph, a portrait of a young man with 
curly hair smiling directly at the camera. The sadness and somber tone depicted 
in the note contrasts with the seemingly happy individual to which the note 
corresponds to; the note talked about how the person and the photo will never be 
forgotten and how they hope that he is in a better place now. That is when I 
realize that this is a mural of individuals that are no longer with us due to an 
overdose. I continue to read other notes, which, like the first, is surrounded by 
sadness despite the happy looking portraits of people next to it. In the middle of 
reading my fifth note, Staff member comes out of the back room, and signals me to 
go to where she is, behind the door that separates the "common area" and the 
"back area" reserved only for those that work at the organization. I stand in the in 
the doorway, caught between the work space meant only for employees and the 
common area when Staff member informs me that unfortunately, they cannot take 
anyone at the moment— Excerpt from field note entry, “Site: Second Attempt” 
(Field note, February 22, 2016). 
Luckily, another manager there interested in my research focus referred me to the site 
where I eventually volunteered and succeeded in carrying out my fieldwork – a place I 
call the X Clinic. The X Clinic is a Hospital-based clinic providing HIV & HCV 
treatment in the greater Boston area. 
After trying many other options, the X Clinic accepted me as an intern. I felt 
elated, and as the old saying goes, the third time is the charm. I could not wait to begin 
the process of building rapport with the organization staff and the patients that frequented 
it. I had a phone interview with a member of another organization that worked closely 
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with the X Clinic, after being connected with her through the site where I had thought I 
would volunteer, and she also referred me to the X Clinic. It was not until much later, 
during one of the staff meetings at the X Clinic, that I met the woman who had so 
graciously introduced me to Sam at the X Clinic. I could not help but profoundly thank 
her when she pulled me to the side and introduced herself, asking me how I liked 
working at the X Clinic. 
Original Research Plan 
Through my ethnographic research, carried out at the X Clinic, I sought to 
understand how people living with HIV, HCV, or both, and who attended the X Clinic, 
perceived the structural risk factors affecting their day-to-day lives. I wanted to identify 
structural risk factors from participants’ experiences of living with HIV and HCV 
syndemics, and of being at-risk for disease clustering and increased suffering. With the 
guidance of my internship supervisor, and participant-observation interactions with health 
providers and individuals living with HIV, HCV, or both, I broadened my research scope 
to include ethnographic accounts from both men and women, rather than just women, as 
had at first thought I might. I aimed to explore participants’ perceptions of their 
vulnerability for structural risk factors that promote syndemic pathways of disease 
interactions.  
Fundamentally, this is a syndemics and modified Grounded Theory (mGT) 
project designed using mixed-methods approaches. I posed the following research 
questions, to explore the structures of risk affecting a marginalized population:  
 41 
How and why do people living with HIV, HCV, or both, in the greater Boston 
area, experience their risks for HIV and HCV syndemics? 
How do people perceive and experience these diseases, and interactions between 
them, under adverse conditions?  
Furthermore, how do structures of risk, as perceived among patients and 
providers, influence syndemic production?  
In other words, I wanted to know how patients and providers describe risk environments 
and structures of risk for syndemic pathways of disease interactions, in the greater Boston 
area. Guided by the theory of syndemics explored within Medical Anthropology, my 
open-ended research questions reflect the overall purpose of the study, which was to 
ethnographically investigate HIV/HCV syndemics in the greater Boston area.  
This project was originally conceived to explore how women, as a marginalized 
population, and their health providers, understand how the prevalence and interaction of 
HIV and HCV infections, co-infection, vulnerability, and susceptibility are exacerbated 
by cultural, gender-specific, and socioeconomic barriers to the reduction of risk 
behaviors, health care access and social services (Cachay 2014; Grebely et al. 2013; 
Mehta et al. 2005; Moore 2011; Oramasionwu et al. 2014; Ostrach and Singer 2012a; 
Robinson and Moodie-Mills 2012; Wolfe et al. 2010). In so doing, I had hoped to 
increase social science, medical anthropology, ethnographic, and syndemic 
understandings of the structural factors and lived experiences that shape disease 
interactions and risks for HIV and HCV syndemics, for marginalized women in the 
Boston area. As my research design and preliminary recruitment began, however, 
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participant-observation at the X Clinic quickly demonstrated that I needed to expand the 
sampling strategy and focus of the study to include all X Clinic patients living with HIV, 
HCV, or both, and their providers, to fully examine the structures of risk for interactions 
between HIV and HCV. 
Initial Planning and Recruitment Strategies 
I employed mixed-methods ethnographic data collection methods at the X Clinic 
over a period of eight months (March through October 2016). I gathered data from 
participant-observation interactions in the form of field notes journaling, where I 
maintained a daily reflective and private journal used to collect de-identified 
ethnographic field notes. I employed purposive, opportunistic, expert, and convenience, 
sampling strategies to gather ethnographic, quantitative, and interview data. I also 
observed how patients living with HIV, HCV, or both, interacted with their mental health 
providers or primary care providers, or social workers, or in the X Clinic food pantry.8 I 
also had many opportunities to directly interact with eligible participants, as a volunteer 
(Spanish) translator, HDAP re-application facilitator, and ad-hoc patient navigator, at the 
X Clinic. 
I originally planned to use purposive and opportunistic sampling strategies to 
recruit participants with whom I would have built rapport. I planned to conduct semi-
structured, open-ended interviews in English and Spanish, and I expected each interview 
to be up to an hour long. I expected to distribute recruitment flyers in Spanish and 
                                                 
8 Of the 35 participants who shared their experiences with HIV, HCV or both, 11 reported 
experiencing food insecurity. Of the 11 individuals experiencing food insecurity, 7 were women, 
and 8 were men. See Table 2. 
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English at the X Clinic. I originally intended to focus most my data collection on direct 
interactions with X Clinic patients, and to merely triangulate the findings with some key 
informant interviews with providers.  
Approved Research Activities 
The Boston University Medical School Institutional Review Board (IRB) 
determined my revised 9 protocol exempt in the spring of 2016. The secondary IRB 
protocol I was nevertheless required to also submit to the X Clinic’s parent hospital’s 
IRB was determined expedited and approved on August 31, 2016. The IRB approvals 
included permission to analyze field notes I had been collecting since the beginning of 
the internship. Altogether I collected ethnographic accounts of the day-to-day 
experiences of a total of 35 people diagnosed with HIV, HCV, or both, directly from 
them, or from their X Clinic providers (Table 2) to quantify syndemic factors. Following 
IRB approval, I conducted in-depth interviews with 14 people living with one or both 
conditions, and with eight health providers.  
From March through October 2016, I completed three shifts per week in the X 
Clinic. While volunteering in the site, I wrote down quick short-hand field note 
observations. I conducted participant-observations during pre-clinic hours, conference 
calls, weekly staff meetings, and monthly presentations, and while interacting with 
patients and shadowing their appointments. I would transcribe these de-identified notes, 
uploading them to NVivo after hand-coding them within the week; I transcribed open-
                                                 
9 The Boston University Medical School IRB determined the initial project protocol EXEMPT 
and approved it on March 15, 2016; the amended protocol was approved July 5, 2016. 
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ended interviews from the formal IRB-approved study period within the week to capture 
the most accurate depiction. I developed my code-book using existing literature, field 
notes, and preliminary transcripts and I would revise it whenever I had new codes or new 
connections between codes. I spent a great part of the summer reading multiple forms, 
documents and guidelines on the X Clinic’s IRB site in efforts to meet all the 
requirements and specifications. I also expanded my reading and research notes on my 
bibliography, by reading about HIV, substance abuse and mental health. 
Revised Recruitment and Enrollment Strategy: Version 1 
I only had access to de-identified information from participants eligible for the 
project. Thus, prior to, during and after the research study, I did not have access nor keep 
any identifiable characters such as names, telephone numbers, or electronic mail 
addresses. For the second version of IRB protocols required by the X Clinic’s parent 
hospital, I wrote a more detailed oral consent statement, which I relabeled as the 
“research pamphlet” per the X Clinic IRB requirements. I further revised my IRB 
protocol to elucidate more detailed procedures to de-identify and store the gathered data. 
However, the version varied from the original plan in the recruitment strategies. The 
revised IRB protocol reflected the language and credential limitations I experienced with 
the X Clinic IRB requirements for distribution of recruitment flyers, which were more 
stringent than the medical school/hospital IRB at my home institution, which had already 
ruled my study exempt. For example, if I wanted to enroll Spanish speaking participants, 
the X Clinic required that I complete a training course in Spanish, even though I am 
Dominican, Spanish is my first language, and I learned English as a teenager after 
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coming to the United States. Another option was to have the Primary Investigator, who 
was not involved at my research site. Unfortunately, due to these irrelevant and 
insensitive IRB constraints I was unable to recruit Spanish-speaking participants for base 
field notes. Thus, I wasn’t able to include Spanish-speakers’ experiences in my 
quantitative analysis of syndemic risk factors.  
Revised Recruitment and Enrollment Strategy: Version 2 
Although the X Clinic’s parent hospital’s IRB would not allow me to directly 
recruit participants, under the protocol they finally approved staff at the X Clinic 
introduced me to willing participants who were 18 years old or older, and met the criteria 
of living with either HIV, HCV or both. The social worker who acted as my key 
informant ensured awareness of my study among clinic staff by speaking with other 
providers. This endorsed recruitment method, along with my volunteering and 
availability as a translator within the site, made my presence more tangible and my 
research more approachable. Reminding the staff of my research interests and daily 
approaching them to ask if I might shadow their appointments with patients connected 
me to physicians, case managers, and other staff who became interested in my research 
and whom I eventually asked to interview. Nevertheless, it all depended on if the patient 
was willing to allow me to observe their appointment. At times, the providers’ 
perceptions, complicated by a patient’s mental illness status or disclosures about sexual 
practices, prevented my observation during those appointments, despite my IRB-
approved status as a researcher, as well as being a confidential volunteer and medical 
translator in the clinic. At all times, I deferred to provider or patient preference about my 
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presence or absence in each clinical encounter. The providers at the clinic also awaited 
my dual IRB approval before referring me to patients for semi-structured interviews. 
Preview of Outcomes – Emerging Themes 
For my data analysis, I used modified grounded theory (mGT) data collection and 
syndemic analysis. I used a quantitative syndemic analysis of factors gleaned from the 
qualitative data that I gathered from or about all 35 participants living with HIV, HCV, or 
both. I conducted fourteen in-depth, semi-structured interviews with women living with 
HIV, HCV or both (no men volunteered for an interview), and eight interviews with 
providers who serve the population. Thus, this combination of data sources yielded the 
biological, structural factors, and contextual information, described by participants about 
their lived experiences with HIV/HCV syndemics, HIV/mental health syndemics, 
HCV/mental health syndemics (see Table 2), and the role of substance use in interactions 
between HIV and HCV, and for increasing risks for both. These structures of risk, the 
disease interactions they produce, and how people experienced them, are the themes and 
pathways I will present and describe in the following chapters.  
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Table 2. Descriptive statistics, biological conditions, and structural contexts of 
people living with HIV, HCV, or both. 
 
Qualitative Data Analysis 
My qualitative data analysis plan included an analysis of emerging or apparent 
syndemic interactions, and modified grounded theory. I hoped to enrich my data quality 
by using different research tools and methods to collect and triangulate the data at the 
analysis stage. I had planned to analyze the experiences of patients as reported in 
interviews, triangulating the results with my participant-observation field notes, de-
identified transcripts of open-ended semi-structured interviews with the X Clinic staff, 
and pre-existing de-identified intake forms and HDAP applications from of HIV, 
hepatitis C, and HIV/C infected patients from the X Clinic. My interest in the effect of 
social and political-economic factors on the relationship and interactions between two 
biological factors, in this case HIV and HCV, pointed my study toward the field of 
 Women (17) Men (18) Total (35) 
Ethnicity/ Race    
African-American 6 5 11 
African Immigrant 1 2 3 
White, Caucasian 4 4 8 
Haitian 1  1 
Latino(a)  5 5 
Other (includes self-identification as “mixed 
race,” and “Brown American”) 
5 2 7 
Biological Condition    
Living with HIV but not HCV 13 12 25 
Living with HCV but not HIV  4 4 
Living with HIV and HCV 4 2 6 
Mental health conditions/ history of 9 6 15 
Social, Structural Context    
Substance use/ history of 10 12 22 
Food insecurity 7 4 11 
Unstable housing/ homelessness/ history of 8 6 14 
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syndemics. I planned to use a syndemic and modified Grounded Theory (mGT) approach 
to gather data, and modified grounded theory and descriptive statistical analysis to 
analyze it. I wanted to employ methodological approaches from modified Grounded 
Theory (mGT) and syndemic theory to expand an understanding of HIV/HCV syndemics, 
in this case through the experiences of marginalized individuals in the Boston area. I 
hoped to ethnographically explore perceptions of vulnerability and susceptibility to these 
syndemic interactions, and elicit people’s experiences of living with these diseases and of 
being at-risk for them. Unfortunately, despite arrangements and discussions from the 
beginning of the project, the staff members at the X Clinic never shared de-identified 
intake and HDAP documents with me, and so I was not able to triangulate my interview 
and field notes data with these sources.  
Modified Grounded Theory (mGT) 
I designed this study using an mGT approach to data analysis; as described earlier 
the de-identified data that emerged from my participant-observation field notes 
influenced the open-ended questions in the Interview Guides for both the X Clinic 
patients with HIV, HCV or both and for the X Clinic staff members. I constantly 
compared the different types of data I gathered. I used open-ended questions to gather 
lived experiences from both patients and staff members during semi-structured 
interviews. When I transcribed the interviews, all interview notes and transcriptions were 
de-identified. I manually coded my documents and then used Nvivo software to keep 
track of all my documents. Dr. Bayla Ostrach, my faculty advisor and the PI on the B.U. 
Medical School IRB protocol graciously assisted me to develop a list of codes to 
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categorize and organize the findings emerging from the study’s de-identified data 
gathered via mixed-methods approaches described earlier in this section. I coded in 1) 
initial coding; 2) memo-writing. I used hand-coding because it allowed me to color code, 
annotate, shorthand, simplify, and learn/get a deeper understanding by processing the 
information as I wrote it down (Charmaz 2014).  
I coded my participant-observation field notes from the on-going internship and 
then fieldwork, multiplied times. This helped me focus the research aims when I coded it 
for the second time, a process in modified Grounded Theory meant to ground the 
evidence in data from the research project (Charmaz 2014). I typed extended memo 
entries to correspond with the participant-observation field notes in my physical 
notebook, the night of the event or situation.  
Syndemics Theory 
I planned to explore how, in the context of social disparity, structural risk factors 
such as homelessness, unemployment, substance use, lack of health insurance, 
immigration status, history of domestic abuse, etc. produce or exacerbate interactions 
between and risks for HIV and HCV. Therefore, my data analysis heavily depended on 
the data emerging from my field notes and interviews. I analyzed the social, political, 
economic and biological conditions emerging in the various data sources not only 
through modified Grounded Theory analysis of interview and field notes transcripts, but 
also using syndemics analysis, under the guidance of my advisor, a recognized expert in 
syndemics (Singer et al. 2017). We created an Excel spreadsheet to track and quantify the 
frequency with which the 35 participants living with HIV, HCV, or both, had reported 
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specific disease or structural factors, and in which combinations of lived experiences, to 
quantitatively evaluate the apparent syndemic interactions between the qualitative 
experiences they described to me or to their providers. Throughout the data analysis 
period, we met regularly to analyze my data and discuss the relationships between the 
disease, biological, behavioral, social, and structural factors that participants reported, in 
relation to known syndemic models and published literature. This quantitative analysis of 
qualitative data (Creswell 2013), and iterative, modified Grounded Theory analysis 
process, allowed me to develop a conceptual schema of the emerging syndemic 
relationships in my participants’ lived experiences of HIV/HCV syndemics (Chapter 
Three), with syndemic clustering (Chapter Four), and with substance use syndemogenesis 
(Chapter Five). I thus used syndemic frameworks and analysis to identify the social, 
political, economic factors that appeared to have the greatest influence on either the risk 
of acquiring an HIV/HCV co-infection, or exacerbating the damaging health and 
structural conditions of a person who is living with HIV, HCV, or both, within the Boston 
area (Gonzalez-Guarda et al. 2011a).  
Adding to the current HIV/HCV syndemics literature, my data documents 
ethnographic accounts of syndemic interrelationships between sufferers’ experiences with 
HIV and HCV in the Boston area. Investigating these syndemic interrelationships drew 
attention to the production and exacerbation of the factors that shape how people who are 
at-risk for, or infected with, HIV, HCV, or both, experience these diseases.  
Ultimately, syndemic quantitative analysis of qualitative data revealed pathways of 
interaction, contextualized by ethnographic fieldwork and interviews that draw attention 
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to biological, social, psychological, behavioral, and structural factors. For instance, a 
major theme of unstable housing demonstrated how this larger structural form of 
precarity reinforces social instability, increasing risks for substance use, reduced 
medication adherence, and driving HIV/HCV syndemic interactions within this 
population. Furthermore, the combination of unstable housing, food insecurity, and lack 
of access to health insurance access also drove additional syndemic pathways of 
interactions associated with HIV, HCV, and mental health condition syndemics discussed 
in later chapters. 
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CHAPTER THREE: HIV/HCV SYNDEMICS 
 
Patients don’t die of HIV; they die of other causes, mostly overdose— “MCM,” a 
male health provider at the X Clinic (Interview, July 07, 2016). 
 
A Syndemic Analysis of Lived Experiences 
MCM’s somber statement highlights the core elements of my argument: structures 
of risk (e.g., substance use, food insecurity and unstable housing) promote syndemic 
pathways of interaction associated with the production of HIV and HCV syndemics. In 
this qualitative sample, only six of the 35 individuals living with HIV had also lived with 
Hepatitis C; these participants shared with me a series of ethnographic accounts that 
depicted their perceptions of their risks for these interactions. Table 3 represents this 
marginalized group of people living with HIV and a current or past HCV co-infection, in 
the greater Boston area, and the structural risk factors that produced syndemic pathways 
of interaction for them. All six participants dually diagnosed with HIV and HCV reported 
a history of substance use; five experienced food insecurity (making them eligible for a 
free food pantry associated with the X Clinic); four reported unstable housing; and two 
suffered from mental health conditions that would meet criteria for psychiatric or 
psychological diagnosis in the Diagnostic and Statistical Manual of Mental Disorders 
(DSM) (Hauser and Kern 2015; Loftis et al. 2006).  
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Table 3. An overview of participants’ experiences with structures of risk and 
HIV/HCV diagnosis. (Color-coding for specific themes used throughout analytical 
chapters) 
 Women Men Total 
Participants living with HIV reporting current or past HCV 
infection; structural risk factors reported 
(5/6) (1/6) (6/35) 
Substance use/ history of substance use (5/6) (1/6) (6/6) 
Food insecurity  (4/6) (1/6) (5/6) 
Unstable housing or history of (3/6) (1/6) (4/6) 
Mental health conditions or history of (1/6) (1/6) (2/6) 
 
In this chapter I analyze ethnographic descriptions each of the three structures of 
risks mentioned by participants living with both HIV and HCV; I discuss the two 
remaining structural risk factors, food insecurity (see Figure 6) and unstable housing (see 
Figure 8) later in the chapter. I use the compounded experiences of participants’ social 
suffering to explore syndemic pathways of interaction between HIV, HCV, substance 
use, food insecurity and unstable housing.10 Thus, in this this chapter I argue individuals 
living with HIV, HCV or both, in the greater Boston area, encounter specific structures of 
risk for HIV/HCV syndemics (Figure 3), confirming the presence and danger of this 
known syndemic.  
                                                 
10 See Figure 3 for the complete HIV/HCV syndemic model.  
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The HIV/HCV Syndemic Model 
 
Figure 3. HIV/HCV syndemic model: substance use, food insecurity and unstable housing.  
(Cabral and Ostrach 2016) 
 
The conditions facilitating syndemic pathways of disease interaction are color 
coded and illustrated in Figure 3 as overlapping figures. I envisioned this syndemic 
model as three dimensional with rings instead of the circles held together by an upside-
down pyramid structure instead of triangle facing the HIV/HCV syndemic. The triangle 
symbolizes possible biological interactions between two biological conditions affecting 
individuals at-risk for and who lived with an HIV/HCV co-infection (e.g., HIV and HCV 
or HIV/mental health conditions11 or HCV/ mental health conditions). The square at the 
                                                 
11 I chose the term mental health conditions because the participants did not use the term mental 
illness in their descriptions of the mental health conditions they suffer from. See Table 4 for a list 
of the mental health conditions participants reported in interviews and de-identified informal 
conversations documented as participant-observation field notes. 
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bottom represents the HIV/HCV syndemic, which is one of the three HIV/AIDS and 
HCV syndemics12 affecting the lives of the people most at-risk for an HIV/HCV co-
infection. The idea for the model being that if looked from above; the randomly 
overlapping rings will have sections intersection with the structure in the middle. The 
sections of overlap symbolize the factors facilitating pathways of disease interaction, and 
the subsequent suffering. For instance, the spaces where the rings overlap with the center 
structure indicate the environmental conditions (be them social or physical) in which 
structures of risk such as substance use facilitate syndemic pathways of disease 
interaction between HIV and HCV that produce a known HIV/HCV syndemic. 
The empty spaces in the rings suggest that substance use (blue), food insecurity 
(green), and unstable housing (purple) are factors of risks experienced to different 
degrees by those diagnosed with HIV and HCV. The empty spaces symbolize situations 
where biological and social factors are not interacting in a syndemic manner. For 
instance, Singer argues that if only one disease is identified within adverse social 
conditions, then it's not a syndemic because a syndemic conceptualizes how multiple 
biological, behavioral or psychological factors interact to compound deleterious health 
outcomes (Singer 2009). Alternatively, if two or more biological, psychological, and 
behavioral conditions are interacting within a population yet no structural factors are 
identified, then it cannot be a syndemic because it does not consider the contexts 
facilitating and perpetuating these interactions (Singer 2009). Therefore, I chose to view 
                                                 
12 I identified three syndemics: HIV/HCV, HIV/mental health conditions, and HCV/mental health 
conditions syndemics. See Chapter Four: Syndemic Clustering for more information on the 
HIV/mental health conditions and HCV/mental health conditions syndemics. 
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the spaces of non-overlap as the physical and social environments where the processes 
needed to develop a syndemic, such as the risk factors, and larger social, cultural, 
political, and economic systems operating at the macro-level that reproduce conditions of 
poverty, injustice and suffering in a population. Conversely, the places where the risk 
factors, substance use, food insecurity and unstable housing overlap with each other and 
with HIV/HCV biological interactions further complicate the health outcomes and the 
disease experience among sufferers. 
Substance Use: As a Risk Factor 
 
Figure 4. HIV/HCV syndemic model part one: substance use. 
 
Coded blue throughout this document, substance use is a behavioral disease; the 
blurred edges of the Figure 4 above reflect the interwoven nature of social and biological 
pathways of syndemic interaction reflected in substance use as a structural factor. Figure 
4 illustrates one of the three structures of risk that in my findings produced a known 
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HIV/HCV syndemic. The model reflects the role of substance use in pathways of disease 
interaction between HIV and HCV, for those at risk. The following vignette occurs 
during an interview, and it highlights the struggle substance use participants go through. 
 “I am always down for the Good Fight,” Double-0-Seven says as she settles 
down in the only available seat in the private clinic office beside the examination 
bed, a metal chair adjacent to mine. For a long moment, there is silence except 
for the slight rustle of fabric as Double-0-Seven slides forward to the edge of her 
seat. I slowly cock my head to the side, prompting her to continue. “Most people 
can drink and go home. Some people can take medicine – painkillers – and stop 
when they are supposed…” her low wistful voice trails off. 
Suddenly, she shrugs, and her light brown eyes lock with mine. “But some people 
cannot! In addition, if you play around and think you can? You can't! 13 You can't 
win.” She leans back in the chair, arms resting on her thighs as her eyes scan the 
office. I follow her gaze, taking in the blue walls, the white cabinets and small 
sink on the left corner. She studies the bright spots dancing on the wooden desk 
between us as the rays of the morning sun peek through the gaps in the leaves of 
the tree outside the tall window, and into the room. 
A sad smile twists her lips before she continues, “you have to recognize within 
yourself your limits.” She nods her head in a quick succession as if emphasizing 
the resilient nature needed to overcome substance use at the individual level. 
“Sometimes it takes 40 years!” She chuckles to herself.  
“It took me about 35 years to figure it out; it's not too late, though. It's never too 
late. So, you just keep fighting the Good Fight” — “Double-0-Seven” (Interview, 
September 22, 2016). 
 
 
Double-0-Seven,14 was a 55-year-old Caucasian woman who after struggling with 
substance use acquired HIV and later, HCV. Throughout the interview, she repeated the 
phrase “just fighting the Good Fight” as if it were a mantra, to remind herself that she had 
                                                 
13 Using punctuation (e.g., underlying) to reflect emphasized words and phrases. In this case, 
Double-0-Seven shakes her head vehemently, stressing the words, “you can’t.” 
14 Double-0-Seven chose her pseudonym shortly after initiating a quick chat about Russia and 
espionage while inspecting the world map plastered to the opposite wall. 
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fought too hard in her struggle with substance use to yield. At the time, I was not familiar 
with the expression, so I asked her about it:  
[Interviewer]: How has fighting the good fight against substance use affected 
how you managed your diseases? 
Double-0-Seven: I have HIV. I have had Hep C, but I got rid of it through 
treatment. I have no kids… I’ve been… a drug addict and an alcoholic since I was 
sixteen. So, in account of that, it brings me to this table with the HIV and the Hep 
C… It was a direct result of my drug use. It was, you know, from um, that lifestyle, 
that gave me these wonderful15 little diseases (Interview, September 22, 2016). 
 
Being At-Risk: Sharing Drugs and Syringe Paraphernalia  
Double-0-Seven is clearly aware that her history of substance use increased her 
vulnerability for not just HIV and HCV, but additional opportunistic diseases as well. For 
example, in the following ethnographic excerpt she describes how her substance use 
increased her risk for HIV and HCV co-infection: 
HIV and Hep C go hand-in-hand. See, no matter what you do, if you are infecting 
yourself with one, and that is what addicts do when they go messing around with 
needles, you know? …. But I think Hepatitis C goes hand-in-hand with HIV 
because, I for one, got them [both] intravenously [by injecting illicit IV drugs] — 
“Double-0-Seven” (Interview, September 22, 2016).  
Her quote sets the stage for substance use as a structure of risk in HIV/HCV syndemics, 
as it increases HIV and HCV susceptibility, transmissibility, and disease progression.  
Double-0-Seven alludes to needle sharing as a risky behavior practice among 
addicts; as described in Chapter One, sharing paraphernalia for injection drug use 
increases the risk of acquiring both HIV and HCV because the syringe acts as a vector for 
                                                 
15 Double-0-Seven’s voice squeaks in excitement as she stresses the word ‘wonderful’ but her 
cheery tone is too exaggerated and sudden to be genuine happiness. If I hadn’t already known she 
was being sarcastic, her exaggerated eye-roll and grunt would have clued in. It was as if she had 
no patience left to deal with the diseases that plague her daily life. 
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infectious agents. Upon removal from the body, a syringe generates a negative air 
pressure that can trap infectious agents, promoting blood-borne infections such as HIV 
and Hepatitis C (Bulled and Singer 2011). Once the HIV or HCV pathogen is in the 
syringe, transmission depends on the pathogen’s ability to survive outside the human 
body (Bulled and Singer 2011). Levels of transmission also depend on how long an 
infectious agent can survive outside the body – HIV can survive for up to 30 days, while 
HCV can last for eight months at room temperature (Thompson et al. 2003). Thus, the 
substance use practice of sharing drugs through contaminated syringe paraphernalia is a 
risky behavior that increases the likelihood of transmitting HIV and HCV. 
Double-0-Seven knew she was at a high risk for acquiring an HIV/HCV co-
infection because she continued to do heroin and share meals with a woman living with 
Hepatitis C. During the interview, she states, "I know that it was from her because she 
had Hep C and she was yellow as a banana! [Indicating jaundice, a common symptom]" 
(Interview, September 22, 2016). Despite knowing she was at risk for acquiring HCV 
from her friend, Double-0-Seven continued to share syringes and other injection drug use 
paraphernalia with her: "She had her own works, and I had my own works and needles, 
but sometimes, when we did not, we would share," (Interview, September 22, 2016).  
The practice of drug and needle sharing behavior and the social dimensions 
perpetuating this risky behavior could be explained using the concept of social 
lubricants, within a moral economy of drug use (Bourgois and Schonberg 2009) shaped 
by structural violence, criminalization, and stigma. Grund et al. (1996) use the term social 
lubricants to conceptualize how the pharmacological effects of drugs result in altered 
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states of consciousness which then facilitate social interaction and feelings of 
camaraderie. Within a moral economy of needle sharing (discussed below), social 
lubricants also act to facilitate the conscious or unconscious overlooking of known risks. 
Double-O-Seven’s following quote points out how substance use itself increases the 
likelihood of sharing drugs and paraphilia, framed by the concept of social lubricants:   
There is just one thing in common and that is just the common denominator, 
which is to get high. I'll help you if you don't feel good – that is the, camaraderie. 
I'll help you because I know that you don't feel good, if I can, but I'm not going to 
go out of my way to help you because of the take care of my own sickness— 
“Double-0-Seven” (Interview, September 22, 2016). 
She describes the social dimensions of substance use that produce syndemic interactions 
between HIV and HCV. Her description links this behavior to Bourgois (1998) moral 
economy concept. As Bourgois and Schonberg (2009) write,  
[The moral economy serves as] protection from full-blown heroin withdrawal 
symptoms…. [Since] it's considered unethical to leave a person stranded when he 
or she is dopesick unless one is openly feuding with that person. The best 
protection from withdrawal symptoms is to maintain a generous reputation, 
because everyone is eager to help someone who will reciprocate in the future 
(Bourgois and Schonberg 2009:82). 
Applying a moral economy of sharing to an HIV/HCV syndemic could explain why 
Double-0-Seven believes that addicts will persist to share drugs and syringes:  
I am not saying it to be bold and crude, but addicts will share because they are 
sick. Their bodies are sick and their minds are sick. They are not thinking about, 
right at that moment, of what they might catch. They will clean the [needles], but 
they may not have bleach that day. They will clean them as good as they can with 
water… Your body is craving something and you aren’t thinking – you're worried 
about feeling better. You are not worried about catching a disease (Interview, 
September 22, 2016). 
Double-0-Seven, continues, “There are things that can do prevent yourself from catching 
anything! Sometimes an addict just doesn't have that stuff. If they do not have it, then 
shame on them—they had a chance!” (Interview, September 22, 2016).  
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Before we our interview ends, Double-0-Seven admits that she would rather use 
water to rinse her works than nothing at all. Unfortunately, water does not get rid of the 
HCV and HIV that can live in the reservoir of a syringe, thus increasing the likelihood of 
acquiring an HIV, and HCV infection (Hernandez and Sherman 2011; Lin et al. 2013). 
For this reason, her reaction to someone who does not even attempt to care about HIV or 
HCV transmission was much more jarring: 
I know people that are completely off-the-rocker-crazy! These people do not even 
attempt to worry about nothing. They just say, “I don’t care.” 
At that moment, her demeanor changed: she sits up straight on her chair, palm 
flat on her chest as she leans back, recoiling and appalled. “Oh, you don't care? 
No? As a matter of fact, I do care, so I am not going to let you use my works, so 
how's that?!” She turns to me and says, “And I wouldn’t. I never ran with people 
though. I ran with one person. I didn’t run with a group of people. Nobody – no 
addict has a bunch of friends anyway” (Interview, September 22, 2016). 
Shortly after she says this, she hints at the reason why an addict would not have that 
many friends:  
“In my pocketbook, I have NARCAN [a medication used to reverse dangerous 
overdoses], just in case one of my friends decides to overdose or something. God 
forbid it happens, but this is it!” Double-0-Seven pulls out the nasal NARCAN box 
from her bag. “And if anything ever happened, I would have to stop and read the 
fucking directions,” she guffaws while she mimics herself putting her reading 
glasses on to read the instructions. “I got you. I got you. Just give me a minute,” 
she says, while hurriedly pretending to read the instructions. “Wait a minute, he's 
breathing? Oh, okay.” She places the NARCAN right back to its spot in her 
purse (Interview, September 22, 2016). 
 
Double-0-Seven believes she acquired HCV and HIV from her friend after these 
reciprocal social interactions, when they shared drugs and syringe paraphernalia, 
demonstrating her own understanding of the structural contexts of risk for HIV/HCV 
syndemics. She concludes: “it is all risky behavior and it is up to you to protect yourself 
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and to just be aware of what you're doing. And if you mess around and Use*16 [drugs], 
your viral [load] goes up…. Addiction is very bad. You think you can control it, but you 
can't. You can't control it (Interview, September 22, 2016). Thus, self-reported 
experiences of sharing drugs and syringe paraphernalia highlight perceptions of risk, in 
the context of needle sharing, causing both social and biological interactions among 
syndemic sufferers (Bulled and Singer 2011; Singer 2014b).  
Substance Use and Food Insecurity 
It’s bad enough to do the drugs, but it is even worse when you put yourself in 
these “high risk situations” where you can catch [HIV/] AIDS. I already have the 
virus, but I didn’t think… back then, I wasn’t thinking about anything; I was just 
thinking about doing drugs— “ Double-0-Seven” (Interview, September 22, 
2016). 
 
Figure 5. HIV/HCV syndemic: substance use and food insecurity. 
 
                                                 
16 The word “Use” is capitalized because Double-0-Seven uses two fingers to tap the crook of her 
arm, suggesting injection drug use (IDU).  
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Participants’ lived experiences of syndemic interactions fell under what I call 
environments of risk or structures of risk, echoing Singer’s description of HIV risk 
environments (Singer 2014b). Structural violence shapes and maintains these high-risk 
settings17 (Singer 2009). Poverty is a pervasive form of structural violence that 
perpetuates unequal access to services, and disproportionate social suffering (Farmer 
2003b). Conditions of poverty therefore produce multiple environments of risk (Sarang et 
al. 2010). Many people in poverty and suffering from substance use disorders may spend 
money on drugs instead of food (Anema et al. 2015). Double-0-Seven explains that she 
buys pot to get an appetite,18 but unfortunately, both cost money that she does not have: 
It’s bad enough to do the drugs, but it is even worse when you put yourself in 
these “high risk situations” where you can catch [HIV/] AIDS. I already have the 
virus, but I didn’t think… back then, I wasn’t thinking about anything; I was just 
thinking about doing drugs (Interview, September 22, 2016). 
Additionally, there are also people who would rather spend money on drugs instead of 
food (Anema et al. 2015). Conversely, Double-0-Seven explains that she buys pot to get 
an appetite, but unfortunately, both cost money that she does not have:  
Yeah… I don't usually um, have an appetite these days, but I smoke pot though. I 
smoke pot a lot, and when I do, I eat, and I don't get in trouble with my doctor. 
[For having poor nutrition that makes her medications less effective]. The thing 
is, that [pot] is expensive; they [sic] costs money, just like everything else, and 
that's it. I can’t… (Trails off) — “Double-0-Seven” (Interview, September 22, 
2016). 
Double-0-Seven thus described some of the structural conditions in which she and others 
with both HIV and HCV live, produced by and compounding daily poverty, in which 
                                                 
17 See Chapter One: Background. 
18 Double-0-Seven’s HIV and HCV medications are associated with side effects including nausea 
and appetite suppression. 
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substance use increases risks, and influences her appetite and wellbeing. She uses pot to 
stimulate her appetite because is aware that other drugs she consumed to suppressed her 
appetite. Importantly, the literature supports her experiences with drugs and a loss of 
appetite (Brooks 2015). 
HIV/HCV Syndemic: Food Insecurity 
It doesn't hurt to bring [food] back home. If I bring some food, at least I'm 
contributing by bringing food, you know? I'm not working... But [the landlady] 
can't complain and say I am staying at the house for free if I [bring food]— 
“Ronnie,” a former substance user diagnosed with HIV and HCV, living in a 
situation of housing and food insecurity (Field note, April 4, 2016). 
 
Figure 6. HIV/HCV syndemic model part two: food insecurity. 
 
This quote from Ronnie, said while packing a few bags of rice, cans of beans and 
juice from the X Clinic food pantry into a book-bag after a session with his mental health 
counselor, illustrates the interplay between all the structural factors that my participants 
described producing structures of risk for. Ronnie is a Puerto Rican man who frequently 
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visited the clinic on a drop-in basis, without an appointment. While I assisted all six 
HIV/HCV co-infected participants as a volunteer in the food pantry at the X Clinic, there 
were only 11 out of the 35 participants who indicated a need for access to the food 
pantry.  
The partial Figure 6 above illustrates how food insecurity as one structure of risk 
promotes HIV and HCV syndemic interactions among participants who experienced 
economic marginalization in the Boston area. Himmelgreen et al. (2009:404) defines 
food insecurity as “a risk factor for both HIV transmission and worse HIV clinical 
outcomes… [And] HIV increases the risk and severity of food insecurity for HIV-infected 
individuals and the members of their households.” The same dynamics increase risks for 
HCV infection and for exacerbating mutual interactions between HIV and HCV. 
Niecy, a 62-year-old African-American woman living with HIV and previously 
diagnosed with an HCV infection, like Double-O-Seven also reported a history of 
substance use. She explained that her struggles with substance use hindered her ability to 
afford food and housing. At the time of the interview, she was unemployed, with Social 
Security checks as her only source of income. She mentioned she tried to save money 
through food-stamps, a federal program officially known as Supplemental Nutrition 
Assistance Program (SNAP), geared towards financially assisting low-income individuals 
to access food. Below, she highlights how she experienced the link between food 
insecurity, financial instability and substance use:  
When I was struggling with my drugs and alcohol, they had this guy tell me I 
could go and sign up for food stamps, and back then, well, back in the day –they 
still do it, but they are trying to cut down. Back in the day, you can sign up for 
food stamps and they might give you a little cash, and that was the case with me— 
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“Niecy,” a woman living with HIV who also experienced an HCV co-infection 
(Interview, October 21, 2016). 
 
The health providers at the X Clinic also note the connection between food access 
and ability to generate an income. For example, during an interview with Michonne, a 
health provider at X Clinic, she discussed food insecurity as a component of 
unemployment and financial precarity, which also affects the patient’s ability to adhere to 
the HIV or HCV treatments: 
Another thing that can interfere with being compliant to their treatment is that 
many of our patients have troubles in their personal life… Sometimes they don’t 
have enough food, they don’t have a job, or they can’t find a job… Many of our 
patients struggle financially—  “Michonne,” a health provider at the X Clinic 
(Interview, July 28, 2016). 
Michonne’s statement hints at the political-economic systems operating at the macro-
level, restricting access to employment opportunities or financial assistance programs. 
After meeting with Ronnie, Sam, a female mental health counselor at the X Clinic and I 
discussed barriers to treatment that affect his ability to access quality foods. She 
explained: 
Finding affordable housing might be difficult for [Ronnie], particularly since he 
has a history of incarceration. [Ronnie’s] history of incarceration hinders his 
ability to be employed in a more stable job occupation to improve his financial, 
home and food insecurity— “Sam,” a mental health counselor at the X Clinic 
(Field note, April 4, 2016). 
 
In Ronnie’s case, he uses the food pantry as a source of food, which intersects 
with the uncertainty of his housing and financial situation – forms of precarity which in 
turn exacerbate negative health outcomes for people living with both HIV and HCV, as I 
found in this study. During the beginning of a therapy session for which Ronnie allowed 
me to sit in, he referred to his perceptions of the biological interactions between food, and 
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the effectiveness of treatments for his HIV and HCV, as his counselor shared in his 
excitement over Ronnie gaining his strength back due to being on regular medication for 
HIV and HCV. Ronnie acknowledged this was true, especially since he had the strength 
to ride his motorcycle:  “I can't wait to take it out for a spin and not just work on it…” 
Ronnie flashed me a crooked smile, “Yeah, it's good I’m eating and taking my medication 
and I'm feeling better now; that's why it's good I'm stronger now,” (Field note, April 4, 
2016). 
By comparison, a structural risk environment that emerged for my participants 
was the inability to afford quality food over time, as an element of the HIV/HCV 
syndemic -- compounding suffering and increasing the interacting disease burden within 
a population. When Ronnie mentions his weight, he echoes a component of the syndemic 
interactions between access to food, and health outcomes discussed in literature: 1) food 
insecurity is associated with malnutrition and lower body weight, which in turn, affects 
susceptibility to HIV and opportunistic infections19 (Himmelgreen et al. 2009; Ostrach 
and Singer 2012b); 2) lack of access to food influences ability to adhere to HIV and HCV 
treatment (Kalichman et al. 2014), and the effectiveness of these medications. Especially 
in the context of substance use, where the pharmacological effects from the drugs (e.g., 
methamphetamine) reduce appetite and with no energy from food, the immune system 
becomes weak (Hendricks and Gorbach 2009); worsened health conditions may limit 
employment options, which in turn, perpetuates conditions of poverty (Anema et al. 
2015; Brooks 2015). 
                                                 
19 See Chapter One: Background for additional information regarding HIV and nutrition. 
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Food Insecurity and Unstable Housing 
 
Figure 7. HIV/HCV syndemic: food insecurity and unstable housing. 
 
Ronnie explained that he is currently living with a person who he works for as 
someone who fixes things around the house. He tells me about the time he fixed 
the heater to the house he was staying in and that instead of being paid for his 
services, the landlady who owned the house let him live in the basement, free of 
charge. However, Ronnie notes that recently, the property owner has been 
complaining more, saying he isn't doing is job. Ronnie tells me that he thinks the 
property owner is complaining about his lack of contribution to the household as 
an excuse to kick him out. Although he is looking for cheap places to live in 
Massachusetts, he is also bringing in food to help save money on grocery 
shopping and not to rely on the landlady for food— Excerpt from the field note 
entry, “Meeting Ronnie,”  (Field note, April 4, 2016). 
 
Indeed, Ronnie’s access to food at the X Clinic food pantry helps him manage 
financially when he cannot afford to pay rent nor food expenses. Consequently, Figure 7 
illustrates the interconnected linkages between food insecurity and experiences of 
unstable housing.  
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Unstable Housing  
 
Figure 8. HIV/HCV syndemic model part three: unstable housing.  
 
Double-0-Seven recounted how her history with substance use and, or, as she 
called it, the lifestyle, increased her chances of living in the streets. Intrigued by Double-
0-Seven’s use of the emic term ‘lifestyle’ to hint at substance use, unstable housing, and 
more, I asked her to describe what she meant. “Yeah, the streets,” she replied expectantly, 
“You know… The Street” she repeats (Interview, September 22, 2016). In doing so, she 
gives a name to the amorphous place where substance use and other high-risk behaviors 
were part of the “lifestyle,” implying that as if by using the term “The Street,” I should be 
able to picture a certain type of person (e.g., an addict). For instance, Erich Goode 
(1984:218) describes an addict as “…a criminal, a willful degenerate, a hedonistic thrill-
seeker in need of imprisonment and stiff punishment.”  
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Lastly, she describes how she managed to change her living conditions, from the 
streets, to a friend’s or family member’s house:  
I chased down my housing. I chased down everything that I got. Nobody came up 
to me and said “here, I know that you don't feel good, so we got you housing.” 
Nobody did that. You have to go after it. You have to chase it down. And I did! I 
stayed at my friend’s couch, I stated my sisters. I was staying on the sidewalk; I 
was living in the, you know, street. I had no way to live— “Double-0-Seven” 
(Interview, September 22, 2016). 
 
Unstable Housing and Substance Use 
 
Figure 9. HIV/HCV syndemic: unstable housing and substance use.  
 
JJ, a 63-year-old African-American woman living with HIV who was undergoing 
INF-free HCV 18-week treatment, and was the only participant living with HIV and 
HCV and actively homeless at the time of the interview. Two of the six HIV and HCV 
dually diagnosed participants reported a history of experiencing homelessness and the 
remaining two were living in unstable housing conditions. JJ describes her experience 
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with homelessness and how it affected adherence to her medication, by describing the 
shelter she where she was staying at and who oversees her medication:  
Right now, I am homeless and I am staying at the [name of organization]. There 
are only 12 women there. You do your own cooking, do your own laundry. You 
get a chore when you get there. You must call for a bed; you can stay there for 90 
days – three months. They20 do a screening. You got to pee in a cup, and there 
can’t be is any drugs – because the woman that is the head staff there, she’s a 
nurse, so she takes care of our meds— “JJ” (Interview, September 29, 2016). 
JJ must follow these requirements and regulations if she wants to continue living in the 
shelter. By contrast, Ronnie who was also experiencing unstable housing conditions, 
despite fearing that his property owner would kick him out, refused to go to a shelter: “I 
don’t want to live in a shelter. They are too constricting, you know? Living under 
someone else’s rules? No. I don’t want that,” (Field note, April 4, 2016). 
Health providers at the X Clinic expressed that unstable housing and substance 
use hinder the ability to engage successfully in HIV and HCV treatment medication 
regimens. For instance, Dee, a health provider who works on the homeless team at the X 
Clinic notes that, 
When a person ends up homeless... [They] have gone through a lot of loss… a lot 
of things must fall apart for that to happen, typically. So, the daily needs for 
survival are prioritized over daily needs for health, unless it is an emergency… 
Some people might not be housed yet… or might still be drinking… and might just 
not be ready for treatment  (Interview, July 26, 2016). 
JJ echoes Dee’s description of what she went through, and continues to go through, as 
someone experiencing homelessness, “I have lived through a lot of a lot of loss—a lot of 
stuff! Meeting people… seeing things,” (Interview, September 29, 2016). To meet what 
                                                 
20 JJ refers to the health professionals who volunteer at the shelter as the ones who conduct the 
test, but to continue to stay in the shelter, the organization requires a substance use screening. 
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Dee calls the “daily needs of survival” (Interview, July 26, 2016), JJ sought out 
alternative methods to earning money for daily expenses.  
For instance, she would sometimes do a little panhandling in the streets where JJ 
lived in; JJ is surrounded by what Double-0-Seven described as “high risk situations,” 
(Interview, September 29, 2016). In other words, JJ’s experience of homelessness 
increases her risk because she has people engaging in risky behaviors all around her: 
You got a mixture of everybody. You got the homeless, you got the students… You 
got weeders, pill poppers... Some that stare at you. I stare back! I don't say 
anything smart or nothing… you get people that drink, exchange money for drugs, 
and this and that… People that sleep up there… Pee out there. It's a mess there! 
They steal! Constantly stealing. My stuff [was] stolen and my meds were in it!— 
“JJ” (Interview, September 29, 2016). 
Ultimately, ethnographic accounts demonstrate the structures of risk producing syndemic 
pathways of interactions within a known HIV/HCV syndemic, in the Boston area.  
Identified Pathways of Disease Interaction 
Based on both my participants’ accounts and the supporting literature on 
HIV/HCV syndemics, the triangle in Figures 3-9 represented the bio-behavioral links 
between HIV and Hepatitis C, while the overlapping circles represented the biosocial and 
political-economic interactions between substance use, food insecurity, and unstable 
housing. For example, substance use will increase the viral load of HIV and Hepatitis C, 
and interactions between them, through syndemics pathway of interactions. Double-0-
Seven illustrates the socioeconomic and other structures of risk that drive this, as she 
describes what she went through to get money for drugs (substance use) when she was 
unemployed (financial precarity) and living on the streets of Boston (unstable housing): 
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To get your drugs, you must do certain things. To get your money, you must go to 
places where you don’t want to go to. You know, like hallways or whatever! 
Whatever you must do to get your money, you know? From A-Z, whatever it takes 
to get your money! So, you do this *21 and that is The Street — “Double-0-Seven” 
(Interview, September 22, 2016). 
Double-0-Seven suggests that the ability to afford drugs was at the forefront of her 
worries. Thus, economic instability exacerbated her suffering and drove her to seek out 
alternative means of generating income to pay for drugs, such as stealing. During the time 
she was living in the streets, struggling with her addiction, with no job prospects, she 
ended up doing “whatever it takes” to get money to spend on drugs (Interview, 
September 22, 2016). This simultaneously constrained access to safer injecting practices 
and increased the likelihood of engaging in alternate— and dangerous— ways of earning 
money. Double-0-Seven follows up by saying,  
When you are under the influence of drugs, there is no difference. You will get 
beat up by a man, even if you have high heels and lipstick, you know? You still get 
beat down…. However, that’s life, you know? You must figure out how to get out 
of it and you must reach your bottom to get back up again. And sometimes it takes 
a lot of beatings, a lot of Street to get to the bottom— “Double-0-Seven” 
(Interview, September 22, 2016). 
Double-0-Seven later says the gender-based violence affected her self-esteem, which in 
turn affected her ability to negotiate safe sex or injection drug use (IDU) practices while 
she continued to live in the street. Risky sex practices increased her vulnerability for 
acquiring an HIV infection (Armstrong et al. 2011; CDC 2016; Friedman et al. 2009; 
Kerr and Jackson 2016; Loeliger et al. 2016). Although sexual transmission of HCV is 
possible, the chances are low (Terrault et al. 2013). Furthermore, the adverse health 
                                                 
21 I use an asterisk before the footnote number, to indicate a behavior or gesture. In this case 
Double-0-Seven makes a swiping motion with her hand, gesturing the act of stealing. 
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outcomes also depend on the type of substance use. For instance, at the individual level, 
high quantities of alcohol consumption affect autoimmune responses, increasing 
susceptibility for additional opportunistic infections (Anema et al. 2015).  
On the other hand, drugs suppress appetite (Anema et al. 2015). This is because 
substance use addiction changes dietary intake patterns, one may assume that drugs affect 
one’s appetite (Brooks 2015). Consequently, the effects of drugs could result in skipping 
meals for a day or more (Campa et al. 2007). Furthermore, over time, weight loss and 
malnutrition weaken the autoimmune system, which may accelerate HIV disease 
progression into AIDS (Duong et al. 2001; Fioravante et al. 2012). On top of that, HCV 
has also been known to reduce appetite levels among its sufferers (Hendricks and 
Gorbach 2009). Not to mention that an inability to afford or lack access to food can 
produce adverse conditions of food instability. At this point, one may be suffering not 
just from HIV/HCV co-infection, but also food insecurity and conditions of poverty and 
unstable housing. Under these compounded conditions, the likelihood of prioritizing 
financial stressors over medical appointments is high (Batchelder et al. 2015a; 
Mendenhall et al. 2012; Olsen et al. 2013). 
Dee described this phenomenon in other patients who experienced homelessness. 
She says, “they were not ready for treatment” because at that point their living 
circumstances become a priority, unless it is a medical emergency (Interview, July 26, 
2016). Missing medical appointments either because of work, or because of experiences 
with financial precocity, jeopardizes one’s health. Especially among people living with 
HIV and HCV. This is even more when the person who experienced conditions of food 
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insecurity in addition to having problems with HCV treatment medication side effects. 
For example, Double-0-Seven shares that her HCV treatment was truly awful: 
I took the Interferon– I tried to take it and I got sick. After two weeks, I was like 
Eugh! *22 But I am a big baby too, so… I’m like: *23 “My stomach hurts, you 
want to go home.” I tell them, but that is just the way it is. But yeah, the interferon 
with the shots? And then, the taking it? Eugh God, I couldn’t deal with it! ... At 
the time, I think I had a cold, and I wasn’t supposed to be taking it. It just got 
very... Not good — “Double-0-Seven” (Interview, September 22, 2016). 
She admits that she should not have been taking the medication since at the time, she was 
sick. When she began her treatment, her suffering worsened to include HCV treatment 
side-effects. The pain she pressed earlier in this chapter made it impossible for her to 
attend her medical appointments, much less can manage her HIV. Her primary care 
physician recommended that she stop taking her ART for HIV management for the 
duration of the HCV treatment since HCV reduces the effectiveness of ART (Miyamura 
et al. 2016; Treloar et al. 2016). If not careful, HIV may become resistant to ART 
cocktail combinations. During the time, Double-0-Seven underwent treatment for HCV, 
experiences with medication side-effects, food insecurity, financial instability and 
HIV/HCV co-infection, exacerbated her health and her health; she reported having a 
slightly higher viral load by the time the medicine cured her HCV.   
Conclusion 
Quantitative syndemic analysis of the qualitative data from and about people 
living with both HIV and HCV in the greater Boston area thus confirms a known 
                                                 
22 Double-0-Seven re-enacted the side effects for me, doubling-over in her chair, holding her 
sides and groaning, as she shared her experiences with HCV treatment. 
23 At this point, Double-0-Seven bends over in feigned pain once more, making sure I understand 
it was a painful experience for he through her exaggerated movements. 
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HIV/HCV syndemic, and illustrates the structural environments that sufferers described 
produce it, in their lives. I used ethnographic data to demonstrate and contextualize this 
HIV/HCV syndemic. In so doing, I showed what drives it in this population and what it is 
like for people to live with these additive risks and their health consequences. I analyzed 
ethnographic data from participants24 who describe how substance use, food insecurity, 
and unstable housing facilitated pathways of interactions between HIV and Hepatitis C 
(HCV), culminating in an HIV/HCV co-infection. To support my argument, I established 
that participants living with HIV and experiencing HCV infections typically had a history 
of substance use and experienced conditions of economic precarity including food 
insecurity and/or unstable housing. 
 In participants' accounts, substance use, food insecurity, and unstable housing 
interacted bio-socially to produce HIV/HCV syndemics. This is evident in the 
experiences of six former substance users diagnosed with both HIV and HCV. Their 
accounts of economic precarity demonstrate the difficulties of accessing HIV and HCV 
services, which in turn, worsened their suffering. Lastly, I analyzed participants’ 
experiences to confirm how unstable housing, coupled with food insecurity and substance 
use, produced higher levels of suffering and disease clustering associated with a known 
HIV/HCV syndemic. 
                                                 
24 See Table 3 for descriptive statistics of the six participants affected by an HIV/HCV co-
infection. 
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CHAPTER FOUR: SYNDEMIC CLUSTERING 
 
I had to be ready to do this [get treatment for HIV]; I was too depressed. Too 
much stress. I was not ready— “Darryl,” living with HIV/mental health 
conditions (Field note, April 12, 2016) 
 
Why Syndemic Clustering? 
Globally, deleterious social, political, and economic factors reproducing 
structures of inequality influenced the rapid spread of HIV and other infectious diseases 
among vulnerable populations (Baer et al. 2013; Bourgois and Schonberg 2009; Farmer 
2003c; Singer 2005). Mark Nichter (2008:157) notes, “[syndemics] is a useful conceptual 
framework for social science investigations into global health inequality that are sensitive 
to environments of risk and agents promoting risk, groups at-risk and risky behaviors.” 
Impoverished groups, subject to structural violence, and marginalization, are at increased 
risk for acquiring or developing adverse health conditions, which also raises the prospect 
and threat of supersyndemics. Supersyndemics25 refers to “synergistic interactions among 
two or more previously independent syndemics” (Singer 2009), within a population: 
It is evident that impoverished populations suffering from numerous structural 
disadvantages and resulting interconnected breakdowns of social infrastructures, 
interpersonal relationships, and immune defenses are vulnerable to multiple 
simultaneous syndemics, which, over time, can merge to form a supersyndemic 
(Singer 2011:13). 
When there is an identified HIV/STI syndemic within a population, there may also be 
other factors that interact in a syndemic manner with HIV, STIs and the bio-political 
                                                 
25 While multiple syndemic interactions associated with multiple syndemic productions hint at the 
possibility of a supersyndemics among HIV, HCV and HIV/HCV co-infected individuals in 
Boston, I would need a larger population sample to confirm a supersyndemics. 
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structural contexts in which they occur (Ostrach and Singer 2012a). In another example 
under conditions of structural inequality, a history of war, or a history of colonization, 
more than one syndemic may develop over time (Singer 2013), and consequently interact. 
To investigate supersyndemics, it is necessary to observe how a known syndemic or 
syndemics interact with other possible syndemics within a population. To do so, 
researchers would have to determine each of the individual relationships between 
syndemic factors, and how these together compound health and suffering outcomes.  
In this chapter, I signal the potential for HIV and HCV supersyndemics by 
exploring syndemic clustering. Though my mixed-methods data with a total sample of 35 
participants did not necessarily fully support an argument for HIV/HCV supersyndemics 
(though, in speaking with Singer, he suggested I might be able to identify one or more, in 
this data), I instead employ the concept of syndemic clustering, to demonstrate how my 
research population experiences multiple interacting and overlapping syndemics. I 
ethnographically describe and analyze their perceptions of the structures of risk driving 
the syndemic interactions that affect them daily. Singer used the idea of syndemic 
clustering (Singer 2014b) to describe multiple risk factors for crack-cocaine syndemics, 
whereas I use it to illuminate the interacting effects of participants’ experiences with, and 
structural risks for, HIV and mental health interactions and Hepatitis C and mental health 
interactions, amid clusters of known risk factors for both HIV and HCV syndemics.  
I also echoed Singer’s (2005; 2011) theoretical framework of social suffering, and 
Mendenhall (2012a) extension of it, syndemic suffering, to analyze participant’s day-to-
day experiences of structural violence and syndemics. I use the terms syndemic clustering 
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or multi-syndemics to argue that, in the greater Boston area, marginalized people living 
with HIV, Hepatitis C, or both, are affected by structures of risk that drive the 
development of not only interactions between HIV and HCV as a known syndemic, but 
other HIV and Hepatitis C-linked syndemics as well – in particular pathways of 
interaction between HIV/mental health conditions (MHC), HCV/MHC, with negative 
health consequences amid disadvantageous social conditions.  
The Syndemic Cluster 
 
Figure 10. Syndemic Cluster: A) HIV/MHC B) HCV/MHC syndemics. 
 
As I analyzed the qualitative data in interview transcripts and field notes to 
compare with the syndemic potential emerging in the quantitative analysis of the full 
qualitative sample, I noted participants’ experiences with HIV, HCV and MHC.26 Fifteen 
of the individuals I interviewed and interacted with shared their experiences regarding the 
contexts promoting HIV/MHC and HCV/MHC syndemics (see Table 4). Table 4 shows 
                                                 
26 For some people, some of the MHC listed in Table 5 overlapped, suggesting interactions 
between these two syndemics. For other people, there was only one set of MHC overlap, while 
the last group experienced different set of conditions from the first two.  
A B
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that nine of the 15 participants described food insecurity; eight of the 15 participants 
reported unstable housing; six of the 15 participants described situations where they 
experienced a lack of positive social support; and lastly, five of the 15 participants 
described HIV- or substance use-related stigma as the driving factor for these syndemics.  
Table 4. Participants’ experiences with structures of risk and HIV/MHC and 
HCV/MHC. 
Contextualized experiences of HIV/MHC and HCV/MHC syndemics  (15/35) 
Food insecurity (9/15) 
Unstable housing/ homelessness/ history of  (8/15) 
Lack of social support (6/15) 
Stigma (related to HIV and/or Substance use) (5/15) 
 
Consequently, Table 5 is a list of MHC reported by participants affected by either 
HCV or HIV such as, depression, history of trauma, anxiety, PTSD and a history of 
addiction. Thus, participants’ accounts revealed how disease interactions contributed to 
the syndemics field, and how vulnerable populations experienced the consequences of 
interacting HIV/MHC (Altice et al. 2010; Batchelder et al. 2015a; Eisenberg and Blank 
2014; Illangasekare et al. 2014; Mustanski et al. 2007), and HCV/MHC (Bulled and 
Singer 2011; Chasser et al. 2017; Craxi et al. 2016; Doyle et al. 2016). 
Table 5. Mental health conditions (MHC) reported by participants living with HIV 
(PLHIV) or HCV. 
MHC mentioned By PLHIV (10) By people living with HCV (5) 
Depression 6 1 
History of Trauma 5 1 
Anxiety 2 2 
PTSD 1  
History of Addiction 8 5 
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Food Insecurity Promotes Syndemic Interactions 
At the time that I found out that I was HIV-positive [in 2006], I had stopped using 
drugs and stuff. The only drugs that were coming into my system was what [were] 
prescribed [to] me — “Niecy” (Interview, October 21, 2016). 
 
Mental Health Conditions (MHC) include the common mental disorders (CMD), 
which manifest as mood disorders such as anxiety and depression (Weaver and Hadley 
2009). This section discusses how food insecurity worsens experiences of CMD 
symptoms among individuals living with MHC, such that inability to access food 
resources causes negative feelings that adversely affect an individual’s experience of 
anxiety or depression. Importantly, participants don’t talk about something as "mental 
illness," but they interact within a clinical setting where those categories are used. The 
social worker/patient never used those terms; referred to a “condition.” 
Food insecurity drives MHC that promotes uncertainty, which in turn, influences 
anxiety and depression engendered by conditions of inequality (Weaver and Hadley 
2009). For example, Niecy, a 58-year-old African-American woman suffering from 
depression and anxiety. She lived in conditions characterized by poverty because the 
HDAP program, which is funded by the Ryan White foundation, covers the co-pays for 
her medication and only low-income people living with HIV27 are eligible for HDAP.  
                                                 
27 See Chapter One: Background for additional information on HDAP and the Ryan White 
Foundation. 
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Financial Precarity 
During our interview, Niecy recalled conditions when she didn’t have enough 
money to go grocery shopping and did not have any snacks or treats for her young nieces 
and nephews who dropped by her home unexpectedly.  
My niece and nephew come over sometimes and I would usually have something 
for them to snack or something, like their parents give them at home. But I hadn’t 
done it [grocery shopping] … it’s tough. I should have had something [to eat]— 
“Niecy,” African-American woman living with HIV and HCV, and suffering from 
anxiety and depression (Interview, October 21, 2016). 
Her low voice and slumped posture hinted at embarrassment, or shame because she did 
not provider her nieces and nephews with anything to eat during their visit. To avoid 
experiencing conditions of food insecurity in the future, Niecy tried to enroll on Food 
Stamps. However, she encountered various issues that delayed her access to financial 
assistance programs.  
Back in the day, you can sign up for food stamps and they might give you a little 
cash, and that was the case with me—in the end. So, I applied for [health 
insurance] but the [health insurance company] were always denying me… I 
mailed the application several times but it was either denied, needed other 
paperwork, or was simply returned to my address and they wouldn’t explain why! 
I stopped trying for a while— “Niecy,” (Interview, October 21, 2016). 
It was weeks later when she finally enrolled on Food Stamps. After sighing, Niecy 
continues, “Sometimes, something happens and it makes you depressed and stuff, but it 
helps you to know how to deal with all of that, so you can move on,” (Interview, October 
21, 2016). Financial precarity shaped the social and structural dimensions where Niecy’s 
food insecurity drove interactions between MHC and HIV. These interactions yielded 
stress-inducing conditions that resulted in higher levels of suffering due to feelings of 
shame and resignation. Individual experiences of inequality, food insecurity thus 
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promoted negative feelings, which could impact Niecy’s mood, thereby exacerbating her 
symptoms of anxiety and depression.  
HIV and Mental Health Conditions 
On a Tuesday afternoon in March: while restocking the X Clinic food pantry 
Raquel, a petite, dark-skinned woman in faded jeans and a pink shirt walks up. I 
smile and reach out to her, letting her know I have yet to finish pulling the canned 
chicken from the boxes. She nods slowly and opens a medium-sized grocery paper 
bag. I use that moment to open the cabinets and wait for her to decide on the food 
items she wants to take home. I anticipate her usual selection of four juices and 
milk, as I reach for the items after her slightest of head nods. Three small bags of 
rice, four juice boxes, one box of milk, one of frozen chicken, four cans of black 
beans, two bags of spaghetti, a bottle of peanut butter, two boxes of raisin bran 
cereal, and a thank you later, Raquel left through the X Clinic back door… 
By September: Raquel has eyes at half-mast, her speech barely above a whisper, 
and her walk more a sluggish dragging of feet; there was no room to engage in 
small talk with someone who seems this tired without inconveniencing her. She is 
a single parent of two young boys, she works full-time as a nurse, and she goes to 
school for a nurse practitioner certification. Raquel's hectic schedule combined 
with her post-traumatic stress disorder (PTSD) and anxiety makes it near 
impossible for her to have a full night's sleep. At the X Clinic, Raquel has an 
assigned mental health counselor to help her overcome her struggles to with 
MHC that affect her ability to adhere to her HIV medication regimen — Excerpts 
from field note entries (March - September,  2016). 
 
These field note excerpts concerning Raquel depict the complex experiences of 
someone in the greater Boston area who lives with HIV, manages MHC, and faces 
adverse structural conditions. The combination of medical and social conditions 
contributed to the stress that plagues Raquel’s, and others similarly affected, daily lives 
and to their experiences with syndemic clustering and suffering (Mendenhall 
2012a). Therefore, those conditions contributed to the syndemic clustering affecting 
people similarly affected by HCV/MHC and HIV/MHC interactions in risky structural 
environments.  
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Food Insecurity and HIV/MHC 
Conditions of food insecurity further compound interactions between MHC and 
HIV. Under conditions of poverty, lack of access to high quality and adequate food 
increased susceptibility to all infectious diseases, through immunosuppression (Farmer 
2003b; 2004; Himmelgreen et al. 2009; Ostrach and Singer 2012b; Singer 2014a). Such 
was the case for my Spanish-speaking HIV-positive participant Paul, who was 
unemployed, had no medical insurance, suffered from depression, and had not picked up 
his HIV medication from the X Clinic for the past three months.  
I outreach via phone to Paul and I speak with him in Spanish. He tells me that he 
didn’t know he had the previous’ month HIV medication supply paid for, since he 
is currently uninsured and without HDAP. He does let me know that he come to 
pick up his medications, although he does not state exactly when he will be by the 
office to pick them up. At his hesitancy, I informed him that he doesn’t have to pay 
for the medications that are already ready for pickup since his previous insurance 
already paid for it in advance. 
At this point, he seems more willing to coordinate a date and we schedule his 
meeting later that day. He tells me that he first must drop of his child at school 
before he can make his way to the office. He tells me that he hasn't had the 
change to go to fill out his application at the health insurance building because he 
doesn't have the money for the travel expenses. I begin to wonder if he can't make 
it to the health care office so that he can get access to his medications, due to lack 
of funds, how likely would it be for him to come in to the X Clinic to pick up is 
medication after spending money on getting his child to school. I think back at 
how Sam will, more than likely provide him with the Charlie cards again. Once he 
arrives, he requests to use the food pantry and take some bags of rice, juice boxes 
and canned beans (Field note, May 10, 2016). 
In Paul’s case, his financial precarity not only affected his nutritional intake because he 
could not afford to make the commute to the X Clinic, but also his HIV viral load which 
increased during the time he was not taking his HIV medication.  
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HCV and Mental Health Conditions 
I lost my job due to a psych incident at work. I was on my HCV medication and I 
was the only person doing work— “Pat” a patient living with HCV and 
undergoing IFN-free treatment for an HCV infection at the X Clinic, and he was 
affected by HCV/MHC (Field note, September 24, 2016). 
 
As for HCV/MHC syndemic interactions, the following excerpt from a field notes 
entry titled “Meeting Ada,” highlights an interaction where Ada allowed me to join her 
appointment with a physician at the X Clinic, because we had previously met at the X 
Clinic food pantry: 
Ada often went by the food pantry at the X Clinic to pick up several juice boxes 
for her baby. At the food pantry, she told me: “Instead of spending a lot of money 
on food, I can use the bit of extra money to pay for things for my baby, 
transportation, doctor co-pays, and whatnot.”  
…Later, during the appointment with her primary care provider (PCP), she 
would explain that her job was in a precarious situation because she was having 
problems with her coworker. With an unstable job position, accessing the food 
pantry helped Ada with the groceries for her daughter— Excerpt from field note 
entry, “Meeting Ada” (Field note, May 26, 2016).  
Ada, a tall woman with dark hair, visited the X Clinic for a monthly check-up with her 
physician. She reported engaging in the practice of cocaine use and a history of high 
alcohol consumption. Cocaine use increased the production of and the consequential 
reduction of a major neurotransmitter group categorized as Catecholamines, (e.g., 
dopamine, epinephrine and norepinephrine) (Brooks 2015). After extensive use of 
cocaine, Catecholamines were depleted, producing depressive effects (Kuhn et al. 2008).  
Furthermore, Ada noted during an appointment with her PCP that “her HCV 
infection was not treated because her depression and low-income status restricted her 
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enrollment to [INF (interferon) based (e.g., Ribavirin)28] HCV therapies” (Field note, 
May 26, 2016). The costly INF-based therapies for HCV infections had a severe neuro-
psychological side effect that exacerbated depression and mood disorders (Goossens et al. 
2016; Hauser and Kern 2015; Ware et al. 2015). This process helped explain the 
biological-behavioral-psychological interaction between HCV infection, substance use, 
and MHC (e.g., depression). 
Food Insecurity and HCV/MHC 
To return to the notion that mental health conditions (MHC) increase of 
vulnerability for HCV infection, MHC or common mental disorders (CMD) affect one's 
ability to partake in sex and drug use practices.29 The aspects that come up in this chapter 
highlight food insecurity as a structural factor driving MHC/HCV behavioral pathways of 
interaction. JJ notes that to be able to take her medication for anxiety, HCV and HIV she 
needs food: “I take my HIV meds. It's three in one. I take it with food every day, once a 
day. Same with anxiety [meds.],” (Interview, September 29, 2016).  
JJ needs food to take her medications although at times, she does not have the 
appetite to eat the food from the shelter, much less the money to afford food outside of 
the shelter. She continues, “I cook sometimes for the shelter. Not now though. [The 
shelter has] certain foods here that I don’t eat… but I can’t get my own [food] outside 
the shelter. It is uncertain,” (Interview, September 29, 2016). Having limited choices for 
food resources and not being able to afford certain foods, may cause JJ’s anxiety 
                                                 
28 Refer to Chapter One: Background for more information regarding treatment for HCV. 
29 Refer to Chapter One: Background, and Chapter Three: HIV/HCV Syndemics. 
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symptoms to become worse because she now faces a level of uncertainty regarding the 
future meals she needs. Uncertainty generates stress that influence an individual's mood 
or experience of MHC (Weaver and Hadley 2009).  
Additionally, Double-0-Seven’s following quote hints at a connection between 
accessible food services, MHC, and the effect of medication for HCV, which may cause 
loss of appetite:  
I don't feel as though I must chase down food services and stuff like that, because 
I'm not sick, *30 and I am not deathly sick where I can't cook for myself. They 
already cook the food, [the organization]. They may not be the greatest, but it is 
something to put in the stomach because people will lose their appetite with the 
meds, you know? (Interview, September 22, 2016). 
Double-0-Seven makes a distinction between first her MHC, and being too physically 
sick when she points to her head, suggesting MHC can impede appetite for food. Another 
factor that she points out, that reduces appetite is the medication taken for HCV. 
Consequently, both Double-0-Seven, and JJ describe experiences of interactions between 
food accessibility, HCV and MHC. They both point out different behavioral pathways of 
syndemic interaction using the same structures of risks (e.g., food insecurity). In doing 
so, Double-0-Seven and JJ shared accounts of different syndemics whereby food 
insecurity promoted multiple syndemic interactions.  
I classified syndemic interactions based on how participants talked about the role 
of food insecurity a structural risk factor in which MHC, HIV, HCV interactions 
exacerbate MHC symptoms and/or weaken the immune system due to a lack of nutrients 
from loss of appetite (Aibibula et al. 2016; Fioravante et al. 2012). Double-0-Seven 
                                                 
30 Double-0-Seven emphasized the word sick as she points to her noggin, to indicate the possible 
adverse mental health condition. 
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focused on food insecurity promoting interactions associated with HCV/MHC syndemics 
that result in worsened HCV medication side-effects. Alternatively, JJ oriented her 
narrative within financial precarity, food insecurity, and experiences with uncertainty 
regarding her ability to afford future meals to ingest with her HIV medications. Thus, JJ 
described conditions associated with HIV/MHC syndemics. 
Structural Violence and Mental Health Conditions 
Many people among the homeless population do have mental illness and access to 
mental health care is not great. Especially for people who can’t keep 
appointments. The people that most need it [health care] … need support getting 
to their appointments; if they missed three in a row usually, they are taken off and 
their health only gets worse— “Dee” (Interview, July 26, 2016). 
 
In the quote above, Dee described the effect of these additional interactions 
between adverse social, psychological and behavioral factors. Thus, Dee suggested a 
form of structural violence, in which people are experiencing homelessness who also 
suffered from MHC, and living with either HIV or HCV are removed from mental health 
care and treatment services if they missed three consecutive appointments. Dee’s account 
underscored the exacerbated interaction between MHC and either HIV or HCV infection 
because a person who experienced homelessness may lose contact with the X Clinic and 
did not have any means for follow-up. Without a fixed address or other contact 
information, it was difficult for case managers and social workers to perform outreach 
attempts. Dee also suggested that the patient’s health deteriorated without financial 
assistance and aid to navigate the bureaucratic process because he or she no longer had 
access to the HIV or HCV treatment medication.  
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Providers echoed their concern regarding their patients’ adherence to HIV and 
HCV medication among individuals who experience financial and housing instability, 
and food insecurity: JayC, a health professional at the X Clinic notes “the [patient’s] 
socioeconomic situation is… Quite chaotic, so sometimes, it’s a challenge for them to 
commit to an eight week or 12-week course of Treatment for Hepatitis C [Treatment]” 
(Interview, August 02, 2016). Especially since these structural risk factors exacerbates 
vulnerability to infectious agents among socially, politically, and economically 
marginalized HIV and HCV populations. 
“A Loss of Opportunity” 
Particularly, unstable housing conditions further promoted syndemic interactions 
because they hindered communication between health providers and patients living with 
either HIV or HCV who suffered from mental health conditions. These, in turn, further 
restricted a sufferer’s access to medication and treatment services due to what Sam 
described as “a loss of opportunity” during our interview.  
A loss of opportunity is the conditions patients living with HIV [and a mental 
health condition] or HCV [and a mental health condition] experience because, 
many of them were using drugs. Many of them were living in poverty, and many of 
them did not come from a place of opportunity (Interview, May 24, 2016).  
“A place of opportunity,” in turn, affected access to housing and food services from a 
very early age. People most affected by Sam’s “a loss of opportunity” (Interview, May 
24, 2016) were the following vulnerable populations: PLHIV, HCV and HIV/HCV who 
live in environments of risks and experience syndemic interactions engender by 
structures of risk (i.e., unstable housing, substance use and food insecurity). The 
compounded health outcomes of these interactions consequently worsen deleterious 
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biological and psychological interactions and its subsequent suffering within this 
population. “A loss of opportunity,” increased the likelihood of malnutrition, food 
insecurity and unstable housing.  
 Lack of Resources and Unstable Housing 
Sam further discussed malnutrition, food insecurity and unstable housing as, 
“issues of lack of resources” (Interview, May 24, 2016). The “issues of lack of resources” 
are akin to the structures of risks that influence the ability to access healthcare and social 
services. However, Sam’s “issues of lack of resources” as its name aptly suggests, are the 
social and political-economic consequences of structural violence, which are individually 
experienced. Throughout our interview, Sam elaborated on the term “issues of lack of 
resources,” by explaining:  
Those suffering from issues of lack of resources conditions are people who are on 
Social Security, on disability, and on those payments to people that are living on 
between 15% and 70% below the Poverty level  (Interview, May 24, 2016).  
Poverty is a form of structural violence, which in turn, operates at the macro-level 
whereby societal, cultural, political-economic systems shape and reproduce conditions of 
inequality within a population (Baer et al. 2013). Under those conditions, the ten 
participants with HIV/MHC and the five participants who experienced an HCV/MHC 
reported living in unstable housing due to financial precarity. Thus, limited access to 
resources expose the power dynamics reproducing disparities within a population. 
Comparing to Syndemic Concepts 
From the participants’ accounts, I posit that the place where individuals suffer 
from “a loss of opportunity,” is akin to an environment of risk, the difference being that 
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“a loss of opportunity” regards the individual behavior, not the social or structural 
environmental conditions that increase the risk for acquiring a disease cluster. 
Consequently, within a syndemic, a person affected by “a loss of opportunity” and the 
resulting “issues of lack of resources,” may individually experience multiple syndemics, 
depending on how they perceive syndemic interactions from their lived experiences. As 
such, these multiple intrapersonal-level interactions do not reflect a supersyndemic which 
includes multiple syndemics interacting within a population. 
Navigating Resources  
Our patients who need help with their SNAP [food stamps] applications, we can’t 
offer those services unless they are living with HIV. HIV-specific federal grants 
fund case managers... only provide services to HIV-positive patients. So, if an 
HIV-positive patient has a problem with their Hepatitis C, we can totally help 
them. But for someone who only has Hepatitis C, but needs help, we must direct 
them to another case manager — “Sam” (Interview, May 24, 2016). 
 
I found that upon navigating access for HIV, HCV and mental health services, the 
health providers at the X Clinic provided a support system for the patients. Django 
suggests that that patients living with HIV and who need case management services earn 
a gross annual income that does not exceed 500% of the federal poverty level, $60,300, 
meaning that these individuals are indeed living in conditions of financial precarity 
(HDAP 2016). The following is a quote from Django, a case manager for patients living 
with HIV at the X Clinic covered by the Ryan White Program and HIV Drug Assistance 
Program (HDAP): 
Case management is designed to be a support system to navigate health care and 
social services. To teach the patients the steps to take medication, and to educate 
them on how medications affect their body…. There are many things that are very 
hard to deal with, just imagine when we call [health insurance company] on 
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behalf of a sick patient and we stay on phone for three hours? It happened last 
year — “Django” (Interview, September 15, 2016). 
Django’s case management services are only for individuals living with HIV. Django’s 
services as a case manager are offered to low income patients living with HIV who 
require assistance navigating the bureaucratic process of pursuing a health insurance 
coverage. Such institutional and political-economic barriers to health care can function as 
a form of structural violence. Often, when structural factors hinder marginalized groups 
(e.g., people living with HIV, or HCV) ability to afford health care coverage, the 
institutionalized aspect of income disparities and social inequality are imbedded in 
people’s daily lives and physical bodies.  
Without access to health care insurance, and no education on medication 
management, the patient may experience ineffective antiretroviral therapy (ART) and 
HAART (Choopanya et al. 2013; Mandorfer et al. 2016; Sayles et al. 2009; Surratt et al. 
2015). People living with HIV who perceive the disease differently are taught by health 
professionals at the X Clinic how to properly manage their condition and prevent HIV 
viral load from rising or developing a resistance to the medications. 
Lack of Social Support  
Multiple providers at the X Clinic expressed concern over the health and well-
being of a patient with HIV with a history of trauma who was engaging in the 
practice of substance use. The providers particularly spoke of his history of 
childhood trauma, unemployment, lack of a social support network. The providers 
did not go into detail about the structural factors that kept this from attending a 
rehab program he had planned to join in Florida. The providers described that 
the sufferer, didn’t understand the bureaucracy process; the suffer was unable to 
attend the rehab program in Florida because he couldn’t afford the move (Field 
note, March 15, 2016). 
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The field note above describes the intersection between lack of support network 
outside of the X Clinic and HIV/MHC. The sufferer, in this case, was enrolled into 
substance use treatment program, which was not available locally, but did not have the 
financial resources to pay for his own traveling. His inability to afford treatments caused 
him to stay in the city, living with a friend, who engages in the practice of substance use.  
The biomedical support was available, but getting to where the clinical help 
awaited them – whether it was a nearby pharmacy, or Florida, was a challenge some 
sufferers couldn’t overcome. As a consequence, another provider at the X Clinic 
suspected the suffer “fell back on to substance use and didn’t get his addiction treated 
since he was surrounded by people who Used,” (Field note, March 15, 2016).  
Adherence to Medication  
The most adherent patients are going to be the one to have a stable place to live, 
stable access to food… [And to] have a steady income. Those patients are rare. 
Those people who aren't being abused or exploited or lacking resources in any 
way, are rare— “Sam” (Interview, May 24, 2016). 
 
Niecy, a 58-year-old African-American woman narrates a nightly routine that 
describes how she takes her medication for HIV, anxiety, and depression. Niecy begins 
by explaining that she hasn’t forgotten or missed a dosage since June 2016: 
I've been on that track since June, and so far, I've been doing good. When I take 
my night meds – I take medicine for anxiety and depression, and I take them only 
at night. When I take those, and make sure I take my HIV meds— “Niecy” 
(Interview, October 21, 2016). 
In doing so, she suggests that between 2006 and June 2016, she may not have always 
taken her medication as directed. MHC are associated with low adherence to HIV 
medication, which results in worsened health outcomes among people living with HIV, 
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such as disease progression to AIDS, and increased suffering from MHC. For instance, a 
substantial body of literature documents the interrelationship between emotional and 
mental health, and HIV progression (DiStefano 2016; Eisenberg and Blank 2014; 
Gonzalez-Guarda et al. 2011a; Martin 2013; Walkup et al. 2008; Wang et al. 2016). 
During the interview, Niecy admits she doesn’t take her medication as directed 
for two main reasons: one, she would like to lower the dosage of her antidepressant, 
Trazodone and two, she usually falls asleep, forgetting to take her medication.  
A year ago, I was taking 300 milligrams (mg) of Trazodone, but I am trying to 
wean myself down, so I cut my dose down from 300 mg to 100 mg. Originally, my 
doctor didn’t want to lower – my doctor wanted me on 400 mg, but I said no—
“Niecy” (Interview, October 21, 2016). 
Niecy expressed a resilient agency when she changed doctors. She sought a different 
doctor because the first one she visited wanted her to have a higher dosage than she 
wanted to have, because she only used that drug to fall asleep. She explains, “I wake up 
in the middle of the night and I go to the bathroom and I go back to sleep. That means I 
don’t need more medicine” (Interview, October 21, 2016). Instead, she searched for a 
different doctor, one willing to at least keep her Trazadone dose at 300 mg before 
lowering it: “I had to go to another doctor –he left me at 300 mg [of Trazodone]. To 
sleep good at night, I take my medicine at night… sometimes I forget [to take] the 
medicines because I fall asleep watching TV,” (Interview, October 21, 2016). If she 
doesn’t take the medication for HIV, depression and anxiety that night, she would then 
have to ingest them the following morning, throwing off her routine.  
Curious, I asked: “Do you take your medication immediately in the morning or 
wait until that night to start your nightly routine over?” (Interview, October 21, 2016). 
 95 
Niecy: I take them like…*31 when I watch TV, it is 9- 9:30 PM, but sometimes, I 
fall asleep, so, when I wake up and go to the bathroom around 12 AM-ish, and if I 
remember it’s like, oh shit! I didn’t take my medicine! So I have to take it now 
(Interview, October 21, 2016). 
When Niecy takes her medication, she knows she will be drowsy afterwards, and those 
feelings could spill over to the following day: “when I wake up at 5 or 6 AM, I sometimes 
get up and start my day, but often, I just lay there and sleep all day” (Interview, October 
21, 2016). Her behavior hints at the association between MHC and the ability to perform 
a social function due to a lack of motivation (Weaver and Hadley 2009). The drug effects 
of the antidepressant medication hindered her ability to adhere to the HIV regimen 
because it disrupted her nightly routine.  
By continuing to sleep, Niecy runs the risk of missing another dose of her HIV 
medicine. The HIV treatment therapy will become less effective, and there is a chance 
HIV may become resistant to antiretroviral (ARV) drugs (Eisenberg and Blank 2014). 
Non-adherence to HIV medication compromises autoimmune systems’ response against 
diseases because the virus may develop a resistance to HIV treatment medications 
(Arends et al. 2015). 
Another participant who had difficulty with her adherence was Raquel, who said: 
HIV, I am positive and... It is a struggle with adherence. And, possibly staying 
alive, I guess. It is so much to summarize 10 years of hard work…. but that is 
because of my ongoing battle with depression…. I hate to say it, I think it's the 
trauma. I think when I was being diagnosed, it's a little bit of PTSD, which I am 
being treated for, through therapy (Interview, September 01, 2016). 
Her quote illustrates the syndemic clustering that I argue produces multiple, potentially 
overlapping, HIV/mental health conditions and HCV/mental health conditions 
                                                 
31 Niecy taps her chin with a manicured index finger as she hums thoughtfully for a few seconds. 
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syndemics. Keeping in mind that non-adherence to HIV medications, increases HIV 
resistance to HAART (highly active Antiretroviral Therapy), which refers to 
combinations of different classes of HIV and AIDS treatment medications. Consequently, 
the increase in viral load accelerates disease progression towards AIDS, which further 
compromises the human autoimmune system’s ability to defend against opportunistic 
infections (Arends et al. 2015; Beste et al. 2015; Fierer et al. 2013).Thus, Raquel 
describes how she uses therapy to treat her multiple mental health conditions, conditions 
which she perceives as intertwined with her history of addiction, and the traumatic 
experience of being diagnosed as HIV-positive, all of which ultimately lower her 
motivation (and hinder her ability to) adhere to HIV medication. 
“Old” Interferon and Ribavirin HCV Treatment 
A lot of our patients have been co-infected for a very long time. And it’s the Hep 
C – they’ve done well on HIV – some of them cannot tolerate the treatment with 
interferon a long time ago and then we were able to tell them, ‘there are new 
medications; it’s well-tolerated’ there was some skepticism for a lot of them. 
Patients would say, “Are you really sure? Because I really suffered when I tried 
interferon” —  “JayC” (Interview, August 02, 2016). 
 
Double-0-Seven underwent the “old” and rigorous Interferon and Ribavirin HCV 
Treatment regimen to treat her chronic HCV. Her story highlights how despite being 
cured of the physical virus, the “six to a year” check-ups and the memory of how the 
HCV medication made her feel HCV persists in affecting her life: 
“I was treated last year with it. I was treated and I got rid of it. The results, after 
two weeks, the viral load was out of me…and the genotype was in my corner to 
say... I got rid of the virus in two weeks.” Double-0-Seven beams up at me and 
just as quickly frowns. She scoffs as she says with what I assume to be a twinge of 
disbelief and outrage, “But still go to see the woman! Every six months to a 
year.” Anticipating my inquiry, she sighs and slumps on her chair in resignation. 
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“Because it was a community research initiative,” she explains. “It was called 
[name of the initiative], and at that time it wasn’t FDA approved— for the 
medicine, but I knew the medicine is going to help me because [Doctor’s name], 
my doctor here, she referred to be and it was up to me to take this, you know? And 
I said ‘sure.’ She [the doctor] wouldn’t lead me down the wrong road, right?” 
She nods in my direction, an eyebrow raised, as if expecting me to agree with her, 
when I nod, she asks once more “ri::ight?”32  
The question hangs in the air. “And I took it and it’s now… two months later? 
They had to come out with Harvoni!” dropping her hand on the desk in 
exasperation. “Which is really what I” – she stops herself and shrugs. “It is just 
different long names, but I took them up in their research, so I had to jump on it.”  
I am left to wonder about how her HCV medication affected her adherence to her 
HIV medication, her social support system, if she could afford her medical 
expenses, trips to the doctor, rent, food and daily expenses during this turbulent 
time, because she waves her hand in the air in front of her. Akin to the sigh of 
relief of someone taking off shoes two-sizes too-small after being on your feet all 
day at work, Double-0-Seven took a deep breath, let it out and stated, “But it’s 
out of me,” (Interview, September 22, 2016). 
She dismissed the idea that her doctor and the organization that treated her HCV might 
have conspired to start her on a dangerous treatment regimen a few days prior to having a 
safer, new, HCV treatment regimen, such as INF-free regimens as an option. Interferon-
free (INF-free) regimen is a Hepatitis C treatment advance developed in 2015 (Goossens 
et al. 2016); however, interferon-free regimens is an exorbitantly costly became are 
available in 2015 (Harper 2015; Stahmeyer et al. 2016) – at least to the individuals who 
could afford the costly fees and co-pays – access to safer treatment options were woefully 
out of reach for individual such as Double-0-Seven who rely on Social Security as their 
source of income.  
IFN-free Treatment Regimen 
A nurse practitioner invited me to observe one of her sessions for the day with a 
patient who had HCV, anxiety and a history of trauma and was at-risk for an 
                                                 
32 The “Ri::ight” has two colons to indicate that Double-0-Seven stretched the word when she 
spoke in the interview.  
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HIV/HCV co-infection. After a short greeting, the patient walks in and takes a 
seat next to me, both of us facing the nurse practitioner. She begins by explaining 
to me that [name of patient] the patient was referred to the clinic by his PCP 
years ago because his [previous] primary care physician [did not accept] his 
health insurance regarding HCV treatment. 
He shares how he had an HIV-positive significant other "who died so very young–
23 years old," he informs us in a somber tone, his eyes down cast, looking at the 
floor tiles. After a few seconds, he looks up and states that he did not know she 
was HIV-positive until she died. When he did find out, he [said he] panicked… He 
was very scared of acquiring an HIV infection because he used to share needles 
with her and that is how he acquired HCV from her… He shakes his head as he 
tells us that all his friends Use[d]… [and] use[ed] his spare bedroom to do drugs 
[and] to get clean, he had to get rid of them (Field note, July 17, 2016).  
 
This vignette illustrates the same pattern of behavior among individuals living 
with HCV who were undergoing treatment or were about to enroll on an IFN-free 
treatment regimen. Distancing oneself from substance use and those who participate in 
substance use seemed to be a defense mechanism for individuals to maintain their 
sobriety or their clean status. For example, in the following field note entry excerpt, Ellie 
makes clear the associations she perceives between how substance use increased her risks 
for, and subsequent acquisition, of Hepatitis C. Interferon-free (INF-free) regimen is a 
Hepatitis C treatment advance developed in 2015 (Goossens et al. 2016):   
A burly man walked in and sat on the closest chair, and the “Ellie,” the health 
provider asks him about his medical history. He shares that he got Hepatitis C in 
the 1980s when he was engaging in substance abuse – cocaine was his drug of 
choice; he stopped using cocaine six years ago and stopped drinking two years 
ago. Ellie then why did he decide to be treated now, after knowing his status for 
so long? He says that his primary care physician referred him to the X Clinic, 
suggesting that he gets treatment. 
When Ellie prompted if he knew of the new medication and how it doesn’t have as 
many side effects as the previous regimen, and it may be his decision to get 
treated was based on that, he said no, that it was because his doctor suggested it. 
Elli nods and begins to check his palms and his stomach, lungs and neck; his 
palms were red in color, which she later tells me might indicate scarring of the 
 99 
liver. She informs me that he might have scarring on his liver because of his 
history with substance abuse. She explains to him that he needs to get blood 
drawn for her to understand what type of Hepatitis C he was living infected with. 
Ellie lets him know that they will also do an Electrography – using sound ways to 
test liver elasticity and that he should come back in a month – the amount of time 
it takes to get all the laboratory results is usually about a month. 
Before he leaves, Ellie smiles up at him and says. “There has been a proposed 
change in health insurance coverage for Hepatitis C treatment. Particularly, in 
August, or after August, Hepatitis C will be treated regardless of cirrhosis 
level”— Excerpt from field note entry, “Ellie” (Field note, July 21, 2016). 
Here, also begin to see a pattern between eligibility for the HCV treatment to hinder on 
the stage of cirrhosis, dating back to Mehta et al. (2005) who proposed a framework to 
understand the low rate of adherence to HCV treatment among HIV/HCV co-infected 
people who inject drugs (PWID). They analyze the data from multiple studies to note that 
some of the individuals chosen for HCV treatment have a high risk of mortality and as 
such, treatment eligibility should be monitored because previously rejected individuals 
might become eligible for HCV treatment at a future date (Mehta et al. 2005). They also 
note that the measurement for liver disease is not uniform and can be too costly.  
Stigma 
Mental health conditions increase the risk of acquiring HIV because mental health 
adversely affect decision-making processes and risk-taking (Agnieszka et al. 2012; 
Singer et al. 2006; Turan et al. 2017). For example, Ann, a mental health counselor at the 
X Clinic further illustrates how individuals who acquired HIV by a sexual transmission 
react to an HIV-positive diagnosis. She brings up one exchange she had with a patient, 
who contracted HIV from her significant other after having unprotected sex:  
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I had one African-American woman say, “It was my fault. It was my fault. I 
opened my legs, it was this thing.*33 This thing wanted me to have sex, and that's 
why I…” and I'm like “that is not why you got infected, you got infected 
because… You got a virus… Let go of the history of HIV, and what it means… It 
doesn’t mean what you think it means”— “Ann”  (Interview, July 07, 2016). 
Ann states what she remembered the same patient telling her during a therapy session, “I 
did this to myself; I shouldn't have sex,” (Interview, July 07, 2016). Ann recalls her reply:  
I’m like… that would've been one way not to ever get HIV… [But] how likely do 
you think that is? As a 23-year-old male? Because… I don't know any 23-year-old 
male who is not going to have sex his whole life because he doesn't want to get 
AIDS. I'm sorry, it is just not going to happen! …Like, you had sex, you did the 
normal, appropriate developmental behavior that you would expect of a 23-year-
old man… same with women (Interview, July 07, 2016). 
Ann describes a patient who blamed himself for his current health condition, and 
internalized HIV-related stigma, which affected his self-esteem. Ann proceeds to inform 
the patient that his perception of HIV does not reflect the biomedical understanding of 
HIV as an infectious agent.  
Sly comments on some of the biological stereotypes associated with HIV and how 
she wishes she could spend some time with people outside of the X Clinic who stigmatize 
people living with HIV (PLHIV):  
They talk negative! And stigma! …I’ve heard [people say], “oh, they are such 
nasty people! You can tell they have HIV because their face is all sucked up!” *34 
I would like [to say] “excuse me, that's not it! … Let me tell you something, I am 
HIV-positive. How you doing? … Look at me, do I look like I have a sucked in 
face?” I could just see the room gasping for air! *35 I would just love to say that, 
and then leave… but I don’t – won’t [disclose HIV diagnosis status] … [because] 
I don't make HIV the topic of conversation… My children don't want to talk about 
                                                 
33 Ann points with one hand to her groin, suggesting that her patient might have also made the 
same gesture when explaining why she had unprotected sex that lead to contracting HIV. 
34 Sly’s voice changes into a mocking nasal voice, to differentiate between herself and those who 
believe and promote negative stereotypes of PLHIV in the community outside of the field of HIV.  
35 Sly gasps for air, demonstrating how she envisions people’s reactions to be. 
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it and neither do I. I haven't found that comfortability to sit and let others know 
what I live with—“Sly” (Interview, October 21, 2016). 
Despite her desire to speak against stigma, she won’t disclose her HIV diagnosis status to 
strangers, much less her family members. Furthermore, Sly is not the only one who is 
aware of how she is perceived just because she is living with HIV, she would also like to 
meet with those who are spreading negative stereotypes, which then lead to PLHIV being 
overly cautious with who knows about their status. Sly continues,  
At another hospital, it was time for me to do a checkup, and a young lady asked 
me if I was on any medication, and of course I had to be honest and tell her the 
truth about my HIV, because I was going in to talk to my liver doctor. So, I told 
her what I was taking and a few minutes later she comes back in with a gown on, 
gloves and a mask. And I wondered if she was dressed like that because of what I 
told her I had HIV… She didn’t have to dress up like that to come here dressed 
like that... That day hurt my feelings so bad! I was so embarrassed… but I let it go 
because I still I had to go on with my checkup and I wanted to get it over with… 
Later, I thought about it, and I was heated! It was the first time that I was 
discriminated against because I live with HIV — “Sly” (Interview, October 21, 
2016). 
 
In the quote above, Sly describes a moment when she felt stigmatized by a 
medical health provider, the emotional distress that she felt while having to endure it for 
the sake of completing her check-up, and the anger she felt afterwards. Sly, a 62-year-old 
woman living with HIV, anxiety, diabetes, and asthma. Sly underwent a year of 
interferon-based treatment to cure her HCV and is a breast cancer survivor. Sly describes 
how within HIV/MHC syndemics, stigma promotes and perpetuates the social structures 
driving biological pathways of interaction between HIV and mental health conditions 
(e.g., low self-esteem, depression, and anxiety) (Emard 2016; Singer 2014a; Turan et al. 
2014).  
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Sly perceives that her HIV-positive status is the cause for the nurse stigmatizing 
her when she came back to treat Sly with multiple protective layers. Sly comments, “She 
harmed me. She hurt me, hurt my feelings. She disrespected me because she had a mask 
on, gloves on and a gown on. Honey, I am not going to give you nothing. All she was 
supposed to do was the paperwork. She didn't have to touch me or nothing,” (Interview, 
October 21, 2016). Importantly, HIV-related stigma refers to the interpersonal process by 
which sufferers and assumed sufferers face social marginalization, which in turn, affects 
the sufferer at an intrapersonal level (i.e., cognitive, emotional, and behavioral 
repercussions) (Earnshaw et al. 2013c; Goffman 1963; Kalichman 2013; Turan et al. 
2017). 
Similarly, to Double-0-Sevem, Sly acknowledges that some of the stigma is partly 
because HIV used to be a death sentence. For instance, Double-0-Seven describes her 
behavioral and emotional experience with HIV-related stigmatization: 
Back then… People didn’t want to talk about it… if you were on medicine – AZT, 
you couldn’t say that because people would say, “Oh no, she’s got AIDS. Oh, 
[she’ll die] soon!” But, back then they were ignorant to the fact that… there is 
HIV and AIDS. So, they are two different things, but people don’t get that, and in 
prison, they really don’t get it and they can be mean and make you feel like a 
leper! I used to go to the window to get my meds and I would say the long name, 
so the girls behind me didn’t know what it was (Interview, September 22, 2016). 
Sly, however, is all too aware that HIV is no longer a death sentence, “It is just disease, 
honey. It is medicated, it is maintained and I do very well, thank you!” (Interview, 
October 21, 2016). This form of enacted stigma affected not just Sly’s perception of HIV-
related stigma, but also Double-0-Seven’s perceived stigma, which ties back into 
HIV/MHC syndemics because these negative experiences affect how PLHIV feel towards 
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themselves and about their HIV diagnosis. As such, Sly comments on the distinction 
between herself and HIV within the context of HIV-related stigma: “It isn't what we live 
with, it is the fear of the name that bothers them. It ain't me!” (Interview, September 22, 
2016). 
Furthermore, individuals suffering from mental health conditions are at an 
increased risk of disease acquisition and progression because illnesses may impair 
judgment, increasing the likelihood of engaging in risky behaviors (e.g., missing medical 
appointments, substance use, needle sharing, and unprotected sex) (Agnieszka et al. 
2012; Compton et al. 2000; Graham et al. 2015; Rivera et al. 2014; Singer 2014a; 
Zickmund et al. 2003). Consequently, facing discrimination from health providers is 
associated with missed medical appointments and loss of physician trust (Graham et al. 
2015; Turan et al. 2017). Thereby, Double-0-Seven’s feelings of shame and Sly’s 
embarrassment, coupled with her desire to leave the hospital as quickly as possible, 
risking ineffective treatment, might stem from the enacted and perceived stigma or the 
personal experiences of stereotyping or discrimination participants encountered in a 
medical setting that affected their trust in their HIV health providers, affecting PLHIV’s 
ability to access health care services (Emard 2016; Lekas et al. 2011; Turan et al. 2017). 
Within the behavioral and structural pathways of disease interaction, Singer 
(2004b) uses the term “oppression illness” to describe the process whereby, after 
experiencing constant stigma or discrimination for a long period, sufferers accept and 
internalize negative perceptions, negatively affecting their mental health (Earnshaw et al. 
2013a; Earnshaw et al. 2013b; Rivera et al. 2014; Smith et al. 2016; Turan et al. 2017), 
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which may consequently manifest within the sufferer in the form of self-blame (Turan et 
al. 2017), further exacerbating risk-increasing behaviors (Chidrawi et al. 2016; Emard 
2016; Rance et al. 2017).  
Discrimination and Lack of Social Support  
People who anticipate stigma shy away from social relationships to reduce 
experiences of discrimination, which then result in social isolation that limits social 
support opportunities (Berger et al. 2001; Parker and Aggleton 2003). Importantly, Sly’s 
experiences of discrimination for living with HIV in the health care field lowered her 
trust in providers. While managing her HIV and HCV, Sly got sick with Kidney stones 
during the time she was supposed to go to the amusement park with her children and 
grandchildren. Nevertheless, she couldn’t go because she was in too much pain, and her 
support system did not accompany her to a hospital: 
I was supposed to go the amusement park, but the kidney stone stopped me from 
going to the amusement park so of course, that arrangement was not canceled. 
They still went! They left me at the hospital when they left they kept saying “you’ll 
be alright, you’ll be alright.” *36 I am laughing now, but at the time heated! 
Because they left me. I had nobody and I was stuck with these morons and at that 
hospital, I had a nurse, and when my daughter found out about what happened, 
she wanted to slap the nurse for me! For real. He got rude, talking loudly about 
my HIV. He kept walking by me, telling he was going to be right there. But there 
he went doing something for somebody else. Somebody else called him and he 
Gowned-up *37 I did some swearing and eventually, I got admitted. It wasn’t a 
long time, but I wanted to go home right away! (Interview, September 22, 2016). 
 
                                                 
36 Sly laughs.  
37 Sly inhales deeply, holds it, and then exhales to calm her down, since she was getting agitated 
talking about it.  
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 Being in pain, and feelings of disrespect and marginalization became worse because 
Sly did not have her support system to help her alleviate feelings of marginalization. 
Indeed, Sly’s feelings of isolation coupled with her perception of HIV-related stigma 
resulted in a loss of positive expectations concerning her behavior and feelings towards 
herself. For instance, Sly’s mood became erratic the longer she was stigmatized and she 
wanted to go home because wanted to avoid feeling unimportant despite being sick: 
Yeah, I was irritated. I was swearing because it was really ostracizing. It was like 
it was put in this bubble where nobody knew I was there but I was in plain sight, 
on the hallway… everybody was ignoring me… and then came the doctor, trying 
to smooth things out and I’m like, she can’t Smooth things out now— it’s too late. 
I had already been stigmatized! I had already been disrespected! So, what you say 
now, ain’t going to mean me no difference. So, do what you do, say what you say, 
but I want to go home. Now! You can’t fix what they made me feel. Tell me what 
she are going to do, because then I was getting a little aggressive and being there 
was giving me anxiety! (Interview, September 22, 2016). 
Indeed, losing her positive support network on a day she needed them the most 
exacerbated her anxiety because she had to manage being in pain from her kidney stone 
while being ignored by the medical health providers at the hospital in a Southern state. 
Sly continues to talk about how experiencing discrimination worsened the interpersonal 
expectations she held towards her medical care:  
First off, the hospital knew me because of my history with drinking and 
drugging… I [also] had no one to help me out and they had me in this hall way 
for almost 2-3 hours. I understand they may have worse patients than me – I get it 
– but give me my respect if you want me to give you yours… Do what you got to 
do but don’t do this again because it hurts my feelings. I didn’t ask to get HIV or 
the kidney stones, but to be disrespected on top of it all? It’s too much. I felt 
worthless. I ended up just saying, “Go ahead ma’am and do what you need to do, 
please, because I am ready to go home. I get off this bed and I am out of here. The 
IV doesn’t faze me. I pull it off and I keep it moving! You can believe that!” 
(Interview, September 22, 2016). 
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Feelings of worthlessness result in erratic behavior that affects how one reacts to health 
care providers, treatment and perceived stigma (Earnshaw et al. 2013a; Edwards 2006; 
Holmes 2002; Jang and Bakken 2017; Zickmund et al. 2003). For instance, Sly tried to 
cut all her appointments shorts, even when the doctors would advise against it.  
I was hospitalized once because of my liver, and my doctor told me I will need to 
stay for 2-3 days and I told him, ‘good, because 4-5 days from now, you will come 
back and you won’t find me in this room. I would call my children so that they can 
come get me, because I don’t want to stay here (Interview, September 22, 2016). 
Feelings of embarrassment, shame and worthlessness can be internalized, eventually 
affecting health outcomes by increasing the likelihood of being unable to access proper 
health care services for fear of being discriminated against (Birtel et al. 2017; Graham et 
al. 2015; Padam et al. 2016; Robinson et al. 2016).  
Conclusion 
In this chapter I presented the pathways of syndemic interaction between HIV and 
mental health conditions, and HCV and mental health conditions, and the structures of 
risk in which they are produced, to expand on Singer’s initial mention of syndemic 
clustering. I illustrated how the 15 out of 35 affected participants experienced this 
syndemic clustering by sharing their accounts that illustrate the HIV/MHC and 
HCV/MHC syndemics. Participants’ narratives demonstrate pathways of interactions 
between mental health factors, HIV and/or HCV, food insecurity, stigma, and unstable 
housing that interact synergistically to produce clusters of syndemic risk factors, and 
social suffering. Anthropological literature has long documented the adverse health 
outcomes of synergistically interacting conditions such as HIV/AIDS, mental health, and 
HIV stigma (Emard 2016; Gideonse 2013; Gonzalez-Guarda et al. 2011a). Participants’ 
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experiences illustrate how structures of risk produce disease interactions, and what these 
are like for people, depicting the structural factors that drove interactions between HIV, 
HCV, and other illnesses and social conditions, producing worsened life circumstances 
and health outcomes. 
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CHAPTER FIVE: SUBSTANCE USE SYNDEMOGENESIS 
The risks for acquiring a dual HIV and HCV infection left a young African-
American man, whose visit I sat in on, spooked. His significant other had passed 
away and he was not aware of her HIV-positive status during the time they shared 
needles and had unprotected sex… During an explanation of HCV and what it 
does to the liver, the female nurse practitioner treating him explains they need to 
do an elasticity test of the liver. She then [told me] that he has been a patient of 
hers for a long time and that he used to have Hepatitis B, but that he was one of 
the lucky ones that cleared it on his own. He cuts her off to let me know that he 
has always been lucky; he was lucky not to have acquired HIV even though he 
shared needles with his deceased significant other and he is lucky to have gotten 
rid of Hepatitis B (HBV) and is looking forward to getting rid of HCV.  
The nurse practitioner takes this time to talk about how there is no need for an 
invasive biopsy if he does the elasticity ultrasound. She goes into detail about 
what it means to live with HCV now that it is curable and the things he should 
avoid, such as excessive drinking. He agrees, saying that the people who used to 
make him drink are no longer people who he associates with, so to him, that will 
not be a problem. She then tells him, the elasticity ultrasound will be enough 
proof for the insurance company that his liver is in bad shape and that he needs 
HCV treatment as soon as possible— Excerpt from field note, “Lucky” (Field 
note, June 17, 2016). 
 
HIV, HCV, and substance use each and all are particularly likely to contribute to 
syndemics, through both biological and social pathways – in other words, they are all 
syndemogenic (Singer 2009). HIV/AIDS is implicated in the emergence of many 
syndemic interactions (Bulled and Singer 2011; Eisenberg and Blank 2014; Emard 2016; 
Gonzalez-Guarda et al. 2011a; Himmelgreen et al. 2009; Illangasekare et al. 2014; 
Mendenhall 2014; Morano et al. 2013; Ostrach and Singer 2012a; Wilson et al. 2014). 
They bi-directionally promote disease acquisition, acceleration, and social suffering 
(Singer et al. 2006) in the form of stigma and discrimination that results from and 
contributes to HIV susceptibility (Bichell 2016; Donnelly et al. 2016; Emard 2016; 
Larney et al. 2015; Rhodes et al. 2005).  
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In this chapter I devote greatest attention to the HIV and HCV syndemogenesis 
triggered by substance use, but I will first discuss the biological/disease and behavioral 
dimensions of substance use and its potential consequences. The behavioral 
consequences of substance use as a biological factor can take various forms, particularly 
through risky sex; a behavior constructed as risky can promote transmission of HIV, 
and/or Hepatitis C, and accelerate liver disease progression (Loftis et al. 2006). Substance 
use interacts with other biological conditions, further driving syndemic interactions. For 
example, alcohol intoxication and other substance use impairs cognitive reasoning, 
increasing vulnerability to needle sharing, and unprotected sex (de Souza et al. 2002). 
Such risk-increasing behavior can also be a coping mechanism for dealing with HIV 
stigma, in a vicious syndemic feedback loop (Emard 2016; Olsen et al. 2013; Turan et al. 
2017; Ware et al. 2015; Wenger et al. 2016). 
Furthermore, within HIV and HCV syndemics (Bulled and Singer 2011; 
Eisenberg and Blank 2014; Gross et al. 2016; Morano et al. 2013), and MHC-related 
syndemics (Eisenberg and Blank 2014; Gonzalez-Guarda et al. 2011a; Martin 2013; 
Mendenhall 2012b; Meyer et al. 2011), substance use both promotes and is the result of 
interactions between biological, behavioral, psychological, and structural factors (Altice 
et al. 2010; Bourgois et al. 2004; Brown et al. 2016; Chen et al. 2015; Eisenberg and 
Blank 2014; Illangasekare et al. 2014; Johnson 2003; Loeliger et al. 2016; Padilla et al. 
2012; Robinson et al. 2016; Rogal et al. 2016; Smith et al. 2016; Wilson et al. 2014). For 
instance, given that HIV infection disproportionately affects those who face social 
inequality and are subject to social marginalization (Bulled and Singer 2011; Farmer 
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2003c; Gonzalez-Guarda et al. 2011b; Mendenhall 2012b; Singer 2013; Singer and Page 
2013), in the context of substance use, marginalized people living with HIV (PLHIV) 
have very limited employment opportunities. Therefore, inequalities shape these 
environments in such a way that the individuals are driven to engage in alternate 
economic survival strategies that further increase their syndemic risks. Consequently, 
these economic strategies are linked to increased vulnerability for disease acquisition, 
progression and MHC symptom development, as I discuss later.  
Not only is substance use an important structural risk factor for facilitating 
syndemic interactions between HIV, Hepatitis C (HCV), and mental health conditions 
(MHC), but participants’ experiences illuminate substance use as a syndemogenic factor 
promoting multiple pathways of interaction affecting those who participate in substance 
use practices. Figure 11 below illustrates the number of participants who reported 
engaging in substance use and some of their preferred substances. 
 
Figure 11. Reported forms of substance use: A) alcohol only B) alcohol and illicit drug use. 
 
A.
B.
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Importantly, Figure 11A illustrates the self-reported substance use of 22 of the 35 
people in this study diagnosed with HIV and/or HCV. Nine of these 22 reported only 
consuming high quantities of alcohol, while the remaining 13 of the 22 reported high 
alcohol consumption together with illicit drug use. Figure 11B depicts participants who 
reported drug use: only eight participants of the 13 who reported both alcohol and drug 
use specified the type of illicit drugs they used. Therefore, Figure 11B shows the four 
participants who a reported cocaine use; two participants who reported heroin use; the 
remaining two participants reported a history of methamphetamine use.  
In this chapter, I present the various pathways of interaction through which my 
participants described the ways their different forms of substance use, as illustrated in 
Figure 11, contributed to their experiences and perceptions of vulnerability for HIV/HCV 
syndemic interactions. Of note, participants used the phrase “suffering from drug 
addiction" to refer to their practice of drug use and drinking to excess. These excessive 
behaviors are regarded as pathological and syndemogenic because they not only worsen 
biological and psychological conditions, but also because people at-risk for HIV/HCV 
syndemics who are actively using drugs, suffering from a history of substance use 
disorders, or drinking alcohol to an excess, tend also to be in social and structural 
conditions in which they experience unstable housing, food insecurity, and lack of access 
to resources or services. 
Structures of Risk 
It is generally believed that drugs of abuse usurp neural circuitry in the brain that 
normally controls responses to natural rewards such as food, sex, and social 
interactions— Chao and Nestler (2004:114). 
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Singer (2014a) explains that a behavioral syndemic interaction may involve MHC 
as the driving factor for syndemic interactions because a mental illness, like or in 
interaction with substance use, also may impair judgement. The psychotropic effects of 
substances such as alcohol (Addicott et al. 2017; Fritz et al. 2010), crack, cocaine and 
heroin (Buchanan et al. 2006; Michel et al. 2016; Singer 2014b; Somlai et al. 2003), 
impair judgment and increase risks for HIV and HCV transmission through a multiplicity 
of identified pathways. Impaired judgement may lead to participating in risky behaviors 
or more difficulty negotiating risk reduction in a high-risk situation (e.g., unprotected sex 
with different partners and needle-sharing) (Bulled and Singer 2011; Lejuez et al. 2005; 
Woerner et al. 2016), thereby increasing the risk of acquiring HIV (Kalichman et al. 
2002; Lansky et al. 2000; McLellan-Lemal et al. 2012; Ostrach and Singer 2012a; Padilla 
et al. 2012), and Hepatitis C (Terrault et al. 2013).  
Risky Sex Practices  
Unprotected sex with multiple partners is constructed as a particularly risky 
behavior because it operates at both the biological and social dimensions to facilitate 
multiple syndemic interactions. Moreover, pathways of interactions engendered by high-
risk sexual behaviors are compounded by mental health conditions (MHC) such as 
anxiety, depression, and suffering from substance use disorders. Substance use practices 
among the 22 individuals38 in my study were shaped by experiences of structural 
violence, poverty, and inability to access resources. Conditions categorized by these 
                                                 
38 See Figure 11.  
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examples of structural violence facilitate interactions that worsen a population's 
vulnerability for disease acquisition, and illness development.  
Earlier, I discussed needle sharing as a risk factor operating within the biological 
and social dimensions of substance use that increases vulnerability to HIV/HCV 
syndemic interactions. I described substance use producing environments of risk, within 
larger structural systems that shape conditions experienced by the individual when 
participating in substance use (e.g., limited access to HCV treatment, food insecurity, and 
unstable housing). Here I use ethnographic data to explore the syndemic interactions 
produced and facilitated by substance use, to increase understanding of substance use as a 
syndemogenic factor in HIV/HCV syndemics, through a multiplicity of pathways. 
Little Flower is a 60-year-old Caucasian women living with HIV and diabetes, 
who suffers from depression and has history of substance use. Little Flower chose her 
pseudonym because it was what her father used to call her when she was young. During 
the interview, she shared that she acquired HIV though a heterosexual exposure from 
having unprotected sex after consuming large quantities of alcohol. What she did not 
know at the time was that her partner, whom she lived with, also participated in the 
practice of injection drug use (IDU): "I resent him for getting HIV and for everything,” 
(Interview, September 23, 2016).  
While intoxicated, she had unprotected sex with her partner, resulting in a 
pregnancy in addition to her new HIV-positive diagnosis. Ultimately, she didn't want to 
give custody of her newborn son to the father, because of his drug addiction, Little 
Flower tried to fight for custody of the child. This process resulted in what Little Flower 
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summarizes as. “The courts got involved” (Interview, September 23, 2016). To treat her 
drug and alcohol addictions, she completed a five-week court mandated rehab program. 
However,  
Even though I completed my program – I did what they asked – I was too sick 
[with HIV and diabetes] to take care of a baby… To give my son a good life, I 
gave him up for adoption… I don't even know if he still alive… It makes me sad 
thinking about it— “Little Flower” (Interview, September 23, 2016). 
At the time of the interview, Little Flower admitted that she missed some appointments at 
the X Clinic, but that was because she did not have the money to pay for the 
transportation. She reported she is engaging mental health services to treat her 
depression, with which she was diagnosed shortly after her HIV-positive diagnosis: “the 
nurse told me, ma’am, you have HIV in the mid-1990s… At the time, they didn't offer any 
counseling… Later, I was officially diagnosed with depression,” (Interview, September 
23, 2016) – further illustrating the relationship between HIV and mental health conditions 
described in the previous chapter. Furthermore, Little Flower’s mental health condition 
symptoms worsened when her ex-husband moved to another state after getting remarried, 
taking her two older sons with him during the time she was still in rehab. 
As discussed in Chapter Four, “Syndemic Clustering,” social isolation may 
increase the likelihood of substance use, which in turn could hinder the ability to manage 
other diseases. For instance, Little Flower’s perception of risk was and potentially is also 
affected by her interacting substance use behavior and MHC. Even now, she smokes 
cigarettes to cope with stress despite being aware that it increases the likelihood of 
developing lung cancer. Little Flower states, “I am waiting for the lab results to tell me if 
 115 
I have lung cancer. It comes back positive, I'll stop, otherwise I won’t,” (Interview, 
September 23, 2016).  
Another participant reported being infected with HIV through heterosexual 
exposure, and suffers from childhood trauma and multiple MHC. During our interview, 
Raquel shared that when she was younger, she drank to excess (Interview, September 01, 
2016). During one of those instances, she had unprotected sex, also became pregnant, and 
was later diagnosed with HIV. Raquel stated she “had to undergo an abortion because 
her body was too weak to carry the pregnancy to full term,” and she could not afford to 
take care of a child when she was first diagnosed (Interview, September 01, 2016). The 
sexual behaviors constructed as high-risk and associated with increased likelihood of 
HIV acquisition mentioned by participants included Sly, Little Flower, and Raquel carry 
very real biological risks for HIV (and HCV) acquisition, but are also socially 
stigmatizing. Furthermore, individuals living with HIV and/or HCV, stigmatized for 
these diagnoses, or suffering from addiction, are also more likely to be socially and 
economically marginalized (Bulled and Singer 2011; Donnelly et al. 2016; Kerr and 
Jackson 2016; Singer and Page 2013; Stall et al. 2009). 
Suffering and Substance Use 
“The immune system is a hell of thing!” Sly’s raspy voice bounces off the walls of 
the enclosed space of the private office. 
“For real. It fights, and it fights. Everyday. I get sick? It’s fighting. I get tired? 
It’s fighting.” She stresses the word ‘fighting,’ and the echo intensifies into a 
chorus of ‘fighting.’ Frowning at the walls, she waits for the echo to fade, “I get 
so worn out at times, but I persist and keep going.” As she speaks, she quickly 
rolls up the sleeves of her hoodie akin to someone who is revving up for an 
impromptu fight and needs to have her hands free to defend herself.  
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“I am a recovering addict on top of it all. That's how I caught them.” Sly nods 
towards her copy of the Interview Guide, as if to indicate she has experienced the 
biological conditions mentioned in the Interview guide, such as HIV and HCV.  
“Doing everything that I had no business doing, but I did it. I did them all and I 
had a ball. I did! I am not going to sit here and tell you that I didn't. I loved to 
Use. It took me places that I had no business going, but I went. And I did it! I 
smiled going, and I smiled going out. Even when I stole from my daughter so I 
can Use again” — “Sly” (Interview, October 21, 2016) 
 
In this telling, Sly perceives her immune system as a perpetual fighter against 
disease acquisition and progression even as she struggled financially in her pursuit of the 
neuropharmacological effects of psychotropic drugs. Sly’s preferred illegal substance was 
crack cocaine -- she suffers from a history of substance use. Sly’s quote draws attention 
to how she is all too aware of how her addiction is perceived, and that she had to steal as 
a means of generating an alternative income. Double-0-Seven and JJ signaled the same 
connection to financial precarity as a structural precursor to syndemogenic substance use 
earlier in chapter three, “HIV/HCV Syndemics,” when they suggested that people who 
engage in substance use often also experience unstable housing or homelessness because 
of their addiction. Sly connects financial precarity and substance use, where the need to 
feel the effects of illegal substances overwhelms the need for anything else, resulting in 
risky alternative means of generating an income to buy drugs (e.g., stealing).  
Drug Use and Alcohol Consumption  
Alcohol intake and drug use are perceived by my participants to be equally risky 
in relation to syndemogenesis, as I noted during one of the mid-day meetings with the 
staff at the X Clinic. As depicted in this discussion of how excessive alcohol 
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consumption promotes adverse health outcomes and suffering within a group of 
individuals living with HIV, HCV, or both:  
During the meeting, which was held in the conference room on the first floor, a 
provider brought up an African-American MSM man who claimed to drink 
excessive alcohol every day. Another health provider then added, “the man’s 
[HIV+] partner also drinks with him.”  
Upon hearing this, the health provider talked about how the individual drinking 
to excess was not concerned about his own excessive drinking, but rather, he was 
more concerned with other health conditions experienced by his partner, such as 
HIV and maintaining a low/undetectable viral load. The African-American MSM 
was believed to be adhering to his HIV medication regime. 
However, when they brought up the subject of drinking, they mentioned that the 
African-American patient first discussed had previously disclosed to his health 
provider that he would drink up to a liter of malt liquor a day and smoke 
marijuana with his partner after work. The providers mentioned the African-
American patient had expressed his excitement over an invitation to an upcoming 
celebration – a day after the celebration, he was admitted to the hospital with 
seizures.  
During the afternoon meeting, his health provider shares that the African-
American man disclosed a use of an illicit drug known as K2 and the health 
providers in the room wonder if fentanyl mixed with K2 might be the cause of his 
seizures. When they tested him for substances, one that came up in his system was 
fentanyl (Field note, March 01, 2016). 
This fieldnote illustrates the social networks existing between HIV+ individuals who 
engage in substance use, especially when participants are an intimate couple. The social 
obligation to attend a celebration, as in the above case, may further facilitate substance 
use, as an extension of moral economies and social lubrication which in turn, can affect 
risks for of acquiring HIV and HCV through needle sharing or via unprotected sex within 
a tight-knit social network intensified by social marginalization and stigma (Martin 
2013).   
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Known Syndemogenic Interactions and Substance Use 
Some days it’s hard… to manage my HIV and HCV… and some days it is mellow. 
I used to try to keep my head calm – avoid [thinking about] drugs. Still, I get that 
stinking thinking, and when that stinking thinking start setting in… I go back 
down memory lane a lot when I am sitting in the house by myself about what I 
used to do when I Used [drugs]— “Sly” (Interview, October 21, 2016). 
 
HIV’s syndemogenic nature is crucial for understanding the structures of risk that 
promote HIV acquisition within vulnerable populations (Singer 2009). To return to the 
pathways within which biological-behavioral-psychological interactions such as HCV or 
HIV interacting with MHC under conditions of substance use, mental health conditions 
and substance use each increase the risk of sexual transmission of HIV (Beadnell et al. 
2000; Dolcini and Catania 2000; Ehrhardt and Exner 2000; Gonzalez-Guarda et al. 
2011a; Hallfors et al. 2007; Johnson 2003; Martin-Subero and Diez-Quevedo 2016; 
Mustanski et al. 2007; Robinson et al. 2016; Singer 2009; Thanh et al. 2009), or of HCV 
(Terrault et al. 2013). In one syndemic pathway of interaction between structural risk 
environments and biological or disease factors, the pharmacological effect of excessive 
alcohol consumption can hinder the ability to negotiate condom use (Fritz et al. 2010; 
Leach-Lemens 2014; Padilla et al. 2012), increase the likelihood of sexual risk-taking, 
and affect medication adherence (Anema et al. 2015; Surratt et al. 2015).  
The practice of substance use shapes risk environments that affect individuals 
differently. Substance use is a structural risk factor with unique syndemogenic qualities 
because it facilitates interactions between HIV and Hepatitis C, and between these and 
MHC. Substance use as a structural risk factor promotes more than one syndemic 
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pathway of interaction, in the context of alcohol consumption or drug use that produce 
syndemic clustering. 
As a syndemogenic factor, substance use and its socially stigmatized “drug 
addict” label further exacerbate health outcomes by promoting interactions between 
biological, behavioral, and structural factors within the context of stigma and self-blame. 
Double-0-Seven’s story  held echoes of self-blame: “I knew had to stop, but I kept doing 
them [drugs]” (Interview, September 22, 2016). Double-0-Seven, living with HIV and 
having lived with HCV, is also a breast cancer survivor, diagnosed with diabetes, and 
asthma. She underwent a Hepatitis C regimen of Ribavirin (RBV) and PEGylated 
interferon-alpha (Peg-INF-alpha) to treat her HCV. Her discussion of her illness 
experiences reflects recognition in the scholarly literature that addiction has adverse 
effects on both mental health and biological conditions, increasing a substance user’s 
susceptibility for acquiring HIV and HCV (Elliott et al. 2016; Martin-Subero and Diez-
Quevedo 2016; Michel et al. 2016; Padgett et al. 2008).  
Knowingly or not, in my interview with Double-0-Seven, she also spoke to 
women’s uniquely increased biological and structural risks for HIV/STI syndemics 
(Ostrach and Singer 2012a), through gender inequality and biopolitical vulnerability. 
Double-0-Seven describes situations where substance use put her in harm’s way, and 
negatively affected adherence to HIV and HCV medication treatments, resulting in her 
own and potentially others’ increased suffering and disease burden among the population. 
 120 
Social Networks 
Risk-increasing social networks among people who use substances were cause for 
concern among health providers at the X Clinic. For instance, during one mid-day staff 
meeting, PCPs and mental health providers discussed a patient living with HIV whose 
substance use issues continuously hindered his ability to keep his appointments and get 
his HIV medication on time. Earlier that day the patient had told Ann, a mental health 
counselor, during their appointment: “I don't know a single person who doesn't use 
[substances].” His statement worried Ann, who sought advice during the group staff 
meeting. She explained, “I am afraid he is circling the drain,” (Field note, March 01, 
2016). 
Niecy’s story 
Without the knowledge of how to manage an HIV or HCV as a chronic condition, 
levels of mental health conditions (e.g., depression) are likely to increase... These 
adverse mood disorders and biosocial conditions are exacerbated if [someone is] 
also experiencing barriers to health care insurance… depression is associated 
with nonadherence to ART because it negatively affects motivation— Excerpt 
from field note entry, “Managing HIV/HCV” (Field note, July 28, 2916). 
 
Niecy, a soft-spoken 58-year-old African-American woman living with HIV, who 
in 2016 celebrated 11 years of sobriety, shared with me how her experiences with 
substance use, HIV stigma, and complicated/inadequate social support networks, 
compounded her risk for, acquisition of, and subsequent progression of, both HIV and 
HCV. When we met, Niecy described situations where substance use, as both a 
behavioral factor and disease (addiction), and a structural factor (substance use as a 
coping mechanism in stigmatized and impoverished communities) drove interactions 
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between HIV, Hepatitis C, social stigma, and depression. Her lived experiences are a 
significant demonstration of substance use syndemogenesis. She began:   
Sometimes I struggled…. with my addiction… Sometimes it comes to my head to 
get high, but I don't act on it. I've been trying to do many positive things to be a 
good role model for my niece and nephew when they grow up. Therefore, they 
don't have to go through the stuff that I went through or deal with stuff that I had 
to…. I got it [HIV] with a guy I had sex with, and he didn't tell me that he had it 
until afterward. I was mad and hurt, [but] then again; I can't be mad and upset… 
I can't hold him accountable because I played a part in it too. I didn't have to stay 
with him— “Niecy,” woman living with HIV and HCV, (Interview 13, October 
21, 2016). 
 
At times throughout our interview, Niecy seemed to feel gratitude towards her 
family; at times, she described being mistreated by them for her struggles with addiction 
to freebasing cocaine and drinking alcohol, and her subsequent HIV diagnosis in 2006. “I 
have two sisters who were struggling with their disease,” she told me, “and they were 
more out there, and they were the ones that got me started” (Interview, October 21, 
2016). However, just as her relationship with her family drove her to substance use, her 
family also became her tether to sobriety:  
I struggled with drugs and alcohol for a part of my life. A stage of my life, as I 
was growing up, I was getting in trouble all the time. Getting locked up. Fighting 
and stuff. And then, like, about 15 years ago, before I got my life together, I lost 
my mother to breast cancer. On her deathbed, she was trying to get me to get my 
life together, you know? But for some reason I couldn't back then (Interview, 
October 21, 2016). 
Niecy describes the structural connections between substance use, mental health 
conditions, social support networks, and risks for HIV and HCV: 
I have a niece that is struggling with the same disease that I am struggling with... 
And [her mother] wish[es] that she would get her life together… But every time 
[my niece] gets to a certain point, her mother intervenes, and I don't know what 
happens, but [my niece] goes back out and starts using again (Interview, October 
21, 2016). 
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Niecy implies that despite having a support network, within the context of substance use, 
the interactions become more complicated, and the risk of developing mental health 
conditions and acquiring HIV is exacerbated. Niecy tries to support her niece who faces 
similar issues by talking to her sister, her niece’s mother. Niecy describes how the stigma 
associated with substance use, and HIV, affects family support networks: 
[My sister] had me sectioned [forcibly committed] to a program, and I used to 
call her.   I used to call her and tell her that I need money and stuff, and she 
wouldn't – [my sister] wouldn’t send me some money in the mail, or she would get 
one of my other sisters to bring it to me. She would not come be with me. And I 
told her that, “you couldn't do those things for me, when I needed you. And I 
know that I'm different from your daughter, but I am still your blood. Therefore, I 
feel you should give her the same benefit of the doubt that you gave me. And if you 
keep, every time your daughter goes in the program, and you find out, now you 
want to say you want to help her, but when she is out there using and with HIV, 
you didn’t want anything to do with her, but now you do! And I think that is kind 
of backwards. I do… (Interview, October 21, 2016). 
Niecy related her substance use to her stigmatized HIV status, in the context of a 
complicated, often un-supportive family context. Even though Niecy is aware of the 
negative dynamic she has with her sister, she places familial bonds above all else, 
potentially internalizing HIV-related stigma. She may also be perpetuating the stigma that 
is part of difficult family dynamics that exacerbate syndemic interactions in her own 
HIV/substance use experience: 
When [my sister] wants to talk to her daughter [Niecy’s niece], she calls me. 
Moreover, I tell my niece, I say, “I know that sometimes your mother makes you 
mad. Sometimes she says hurtful things she might not mean, but that is just her… 
but you must love her from a distance, you know? Try to work around because 
you only have one mother. When she is gone, you have nobody else”— “Niecy” 
(Interview, October 21, 2016). 
Niecy’s experiences of being perceived as an “addict” by close family members on whom 
she relied, yet who stigmatized her behavior, reinforced her substance use, which in turn, 
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exacerbated her suffering and risk of disease acquisition. Substance use, and her family’s 
stigmatization of it, increased Niecy’s risks for acquiring HIV, within larger structures of 
risk. 
As hinted at in her previous quote in this chapter, Double-0-Seven's experiences 
with substance use illustrate a long and hard-fought struggle with drugs and alcohol, 
which was a common risk factor for all individuals living with both HIV and Hepatitis C. 
In our interview, upon comparing her perceptions of needle sharing and substance use as 
risk factors, Double-0-Seven’s narrative strongly coincides with that of her biomedical 
health providers at the X Clinic. During an interview with JayC, a mental health provider, 
he noted that although a person may be actively using, that does not mean they are 
neglecting HIV treatment adherence:  
The difference is that if they are actively… Using, it’s like – you know, let’s say 
they have Hepatitis C, HIV and they have substance abuse, so you have three 
diseases to take care of. 
You have a discussion of whether – assess whether the substance abuse is going 
to get in the way of treating the other two. Now, you can have people who are 
actively… You know, using and abusing drugs and still be very adherent.  
I’ve had people who are actively shooting up Heroin who never missed their dose 
of antiretroviral… You can’t assume that a person that – that a person who is 
using is not going to take their antiretroviral. Therefore, you must make that 
assessment with the patient, to figure out whether they are going to take their 
medication or not. If you think that the substance abuse is going to get in the way, 
just concentrate on the substance abuse and try to… Try to get it to a sustainable 
recovery— “JayC” male health provider (Interview, August 02, 2016). 
Substance use, HCV, and HIV, function as three diseases or conditions for the provider to 
focus on if the patient is “actively using”/ “actively” engaging in the practice of substance 
abuse, since “substance use” is a known risk factor for both HIV and HCV.  
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Although substance use seemed to carry increased risks for acquiring both HIV 
and HCV for all substance users in my study, not all participants experienced HIV/HCV 
syndemics solely in the context of substance use. When I was with Ronnie helping him 
get food from the X Clinic food pantry after a meeting with his mental health counselor 
the day he explained that bringing food home helped to temporarily stabilize his tenuous 
housing situation, his tale made clear that while he might have acquired both HIV and 
HCV in the context of poverty and substance use, the greatest threat for disease 
acceleration, and his health now, is food insecurity, compounded by a mental health 
condition, and substance use stigma.  
Conclusion 
Participants described substance use as a key structure of risk promoting 
syndemic interactions within all three syndemics (HIV/HCV, HIV/mental health 
conditions (MHC), and HCV/MHC – I have argued and demonstrated that substance use 
acts as a syndomegenic factor in HIV/HCV syndemics. It acts to drive the production of 
multi-syndemic clustering among people living with a combination of HIV and/or HCV, 
and many of them with MHC, in the Boston area. 
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CHAPTER SIX: CONCLUSION 
 
 
This ethnographic, prospective, mixed-methods research on the experiences of 
marginalized people living with HIV, HCV, or both in the Boston area yielded original 
and revealing data on multiple overlapping syndemics. I confirmed a known HIV/HCV 
syndemic, and illuminated the structures of risk that produced it, for my participants, six 
out of 35 participants living with both conditions promoted in conditions of food 
insecurity, housing instability and substance use. These conditions also emerged as 
structures of risk for syndemic clustering related to HIV and mental health conditions, 
HCV and mental health conditions, or the confluence of all of these. These structural risk 
factors, as described by my participants, demonstrated what drove multiple syndemics in 
this population. Substance use emerged as a key syndemogenic factor.  
Participants perceived their risk environments for HIV and HCV interactions 
within the context of substance use, and compounded this by their experiences with lack 
of access to resources (in particular, food, housing, and healthcare). Substance use 
created situations that increased their likelihood of excessive drinking, sharing needles 
and having unprotected sex with people who, unbeknownst to them, were living with 
HIV. Participants also talked about how they experience poor living conditions because 
of unemployment or limited income generating opportunities. Participants with a history 
of substance use talked about their struggles to afford food and housing. They relied on 
food pantry services at the X Clinic, federal financial assistance programs (e.g., HDAP 
and food stamps), and their social networks, for access to food, housing, medical services 
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and substances. Under these conditions, they relied on their social networks for 
temporary housing conditions, or were forced to live in the streets due to an inability to 
afford food and housing. Shaped by structural violence, these structures of risk increased 
their risks for syndemic interactions between HIV and HCV. Therefore, participants’ 
lived experiences under these structures of risks highlighted their vulnerability for 
HIV/HCV syndemics.  
Participants described experiences with inadequate social networks and stigma 
that further reduced their ability to access and navigate resources. Moreover, mental 
health conditions (MHC) affect how participants perceive and manage their diseases. 
Participants also noted the risks for HIV/MHC and HCV/MHC interactions stem from 
their history of substance use and stigma. Individual experiences and perceptions of 
interactions between these factors illuminated and contextualized multiple syndemics 
affecting participants living with HIV, HCV, or both. Similar to participants who faced 
HIV/HCV syndemics, while suffering from the adverse health effects of drinking and 
using drugs, and conditions characterized by food insecurity and unstable housing, many 
participants with HIV and/or HCV, also suffered from MHC such as depression and 
anxiety. It is for this reason that I use the term “syndemic clustering” to argue that 
structures of risk produced the syndemics I here identify (e.g., HIV/MHC and 
HCV/MHC syndemics) in addition to the known HIV/HCV syndemic. This expands on 
existing syndemic literature on the intersecting social and biological dimensions in which 
substance use and other structures of risks such as mental health conditions, food 
insecurity, and unstable housing, drive various syndemic pathways of interactions. 
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Analyzing my participants’ experiences of what it is like to live with additive 
risks, I also confirmed substance use as a particular structure of risk with syndemogenic 
properties for HIV/HCV syndemics, as well as other syndemics, in this marginalized 
population in the greater Boston area. I knew that there was a known HIV/HCV 
syndemic, and I identified the risk factors that produced the syndemic among people 
living with HIV, HCV, or both in the greater Boston area. I illustrate how substance use 
facilitates syndemic interactions in each of the three identified syndemics affecting this 
population. Consequently, substance use, as a structure of risk, shaped by structures of 
inequality (e.g., poverty) and as a syndemogenic factor, produced experiences of 
syndemic clustering among my participants.   
Limitations 
Given my participants’ socially and economically vulnerable status, the process of 
gaining access to the research site, building rapport with people living with HIV, HCV, 
or both, and the providers that treat them, was lengthy and complicated; time constraints 
resulted in eight months of field work but only a short period of IRB-approved formal 
recruitment and data collection. While ethnographically rich as a mixed-method study, 
and an important contribution to syndemics research, the quantitative analysis is not 
statistically significant. Syndemic analysis of syndemic interactions may be critiqued by 
epidemiologists, but is recognized as a strength within critical medical anthropology, and 
more broadly. Qualitative and ethnographic data analysis draws attention to perceptions 
of risk, and the structural factors hindering access to health care services and social 
services, thereby increasing the suffering among a vulnerable population.  
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Contributions 
Rooted within Critical Medical Anthropology (CMA) (Baer et al. 2013; Ostrach 
and AbiSamra 2017; Ostrach and Cheyney 2014; Ostrach and Singer 2012a; b; Singer 
1986; 1995; 2004a; b; Singer et al. 2013; Singer and Clair 2003), syndemics theory 
(Singer 2009, Singer et al. 2017) examines the power dynamics involving social, 
structural, economic and political conditions that contribute to disease interactions and an 
exacerbated disease burden within vulnerable populations. My goal was to increase social 
science, medical anthropology, ethnographic, and syndemic understandings of the 
structural factors and lived experiences that shape disease interactions and risks for HIV 
and HCV syndemics, among marginalized individuals in the Boston area. I contributed to 
the body of existing research on HIV/HCV syndemics, illuminated understandings of the 
structural risk factors that cause these syndemics for different populations, and identified 
a new set of syndemics clusters demonstrating additional syndemic risks resulting from 
the same environments of risk and factors. It is also likely that my participants experience 
supersyndemics, but more research would be needed to fully articulate this argument. 
Recommendations 
I recommend further research be conducted to identify the various structures of 
risks for HIV/HCV and mental health supersyndemics for diverse populations. 
Importantly, more ethnographic accounts are needed to further illustrate daily situations 
endured by individuals and communities, to identify the pathways of interactions 
conceptualized within HIV/HCV, HIV/MHC and HCV/MHC syndemics (Bulled and 
Singer 2011; Grund et al. 1996; 2009; 2010). Specially for vulnerable groups (e.g., the 
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impoverished, targets of systemic oppression, those who engage in the practice of risky 
behaviors due to lack of resources or other options, people living with HIV, HCV or 
suffering from MHC) often face health inequities, such as limited access to social and 
health resources, which promote worsened social and health outcomes (Aidala et al. 
2016; Bichell 2016; Bourgois and Schonberg 2009). 
Ultimately, this thesis explored syndemic clustering to argue the same structural 
risk factors produce a known HIV/HCV syndemic in addition to HIV/MHC syndemics 
and HCV/MHC syndemics. I focused on the structural risk factors (e.g., food insecurity, 
unstable housing, stigma, lack of social networks) and how they shape interaction 
between overlapping syndemics. To do so, I analyzed the lived experiences of people 
affected by HIV, HCV and MHC interactions produced and intensified in structurally 
unequal environments – conditions of syndemic risk. The presence of HIV/HCV, 
HIV/MHC and HCV/MHC syndemic interactions suggest how macro-level social 
structures (i.e., structural risk factors) and environments of risk produced by and caused 
by experiences of structural violence and social suffering perpetuate additional syndemic 
interactions within this population in the greater Boston area. 
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